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ABSTRACT 
 
 
The development of complex organic molecules with industrial potential requires 
meticulous synthetic methodologies coupled with detailed investigations surrounding their 
physical properties.  This dissertation encompasses the study of two such projects: (i) the 
synthesis, optimization, and quality control of siloranes for use as a biomaterial (i.e., bone 
cements) and (ii) the investigation of the synthesis, physical properties, and barrier to 
enantiomerization of twisted molecular ribbons. 
 Optimization of the synthesis of the silorane monomers PHEPSI and CYGEP was 
completed via metal-catalyzed hydrosilylation.  PHEPSI was synthesized utilizing a 
monomeric version of the rhodium-based Wilkinson’s catalyst.  The synthesis of CYGEP 
was accomplished using two versions of the platinum-based Lamoreaux’s catalyst (in-house 
versus commercial).  In both cases, formation of CYGEP was accomplished only in those 
reactions in which acetonitrile was present, otherwise polymerization occurred.   A quality 
control investigation found that for use of these monomers as a potential biomaterial, a high 
grade of Wilkinson’s catalyst must be utilized for the synthesis of PHEPSI, while use of the 
iv 
 
commercial catalyst is sufficient for the synthesis of CYGEP.  Mixing of the monomers no 
more than one month post purification prevents the decomposition of PHEPSI. 
 An exploration into the effect of end caps and substitution of the acene skeleton was 
completed.  The synthesis of the target pentacene and anthracene compounds was focused on 
the incorporation of isopropyl substituents while extension of the acene skeleton was 
expanded to the hexacene diol.  The targets were synthesized utilizing a series of Diels-Alder 
and reduction reactions.  The incorporation of the isopropyl substituent was accomplished 
through the use of lithium reagents generated in situ.  The barrier to enantiomerization was 
then studied on the aromatized isopropyl acenes utilizing VT-NMR spectroscopy.  
Coalescence of the methyl peaks in the 
1
H NMR spectrum was not observed at temperatures 
up to 408 K.  Utilizing this method, the barrier to enantiomerization of these compounds was 
found to be greater than 24.0 kcal/mol.  The stages of the synthesis were determined through 
mass spectrometry, 
1
H and 
13
C NMR spectroscopy, and in some cases X-ray crystallography.  
Fluorescence of the isopropyl targets was investigated through UV-Vis spectroscopy. 
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CHAPTER 1 
DEVELOPMENT OF SILORANES FOR USE IN A BIOMATERIAL 
Introduction 
Over the last half century, a significant sector of modern healthcare has been devoted 
to the development and implementation of biomaterials.  Clinical applications of biomaterials 
vary widely, with use in areas from vascular grafts and degradable sutures to orthopedic 
implants.
1-4
  An area that has been of interest to our group has been the use of biomaterials as 
bone cements.  Every year, there are approximately 200,000 hip implant and 300,000 knee 
implant surgeries in the United States.
5-7
  Between the years 2002 and 2006, a majority of 
primary total knee (~85%) and total hip joint replacements (>70%) were cemented.
8, 9
  Since 
its introduction by Charnley in 1960, polymethyl methacrylate (PMMA, Figure 1) has been 
the standard in bone cements.
10, 11
    
 
 
 
 
Figure 1: Methyl methacrylate (MMA, 1) and polymethyl methacrylate (PMMA, 2). 
 
 
 
2 
 
Comprised of two separate parts (powder and liquid), the composition of PMMA bone 
cements has not changed substantially over the last half century.  The powder portion is 
composed of pre-polymerized PMMA beads, a methacrylate-styrene-copolymer, benzoyl 
peroxide initiator, and either barium sulfate or zirconium oxide as a radiopacifier.
12, 13
  For 
the liquid portion, the components are a monomer (methyl methacrylate, MMA), 
polymerization activator (N,N-dimethyl-p-toluidine), and an inhibitor (hydroquinone), which 
is used to avoid self polymerization of the monomer.  In spite of half a century of use, 
methacrylate-based bone cements suffer from several shortcomings, e.g., high exotherms 
(potentially >100 ºC, significant increase over body temperature of 37 ºC), toxicity from the 
leaching of the MMA monomer, and volume change upon polymerization.
5, 9, 14
  Over the 
preceding decades, numerous investigations have focused on developing alternatives to 
PMMA bone cement, targeting the aforementioned shortcomings.
9, 15-17
  Calcium phosphate 
and bisGMA-TEGDMA (bisphenol A glycidyl methacrylate and triethylene glycol 
dimethacrylate) based bone cements have recently been developed with improved properties, 
but both still have their shortcomings as seen in Table 1. 
 
 
 
3 
 
 
Figure 2: Structures of bisGMA (3) and TEGDMA (4). 
 
 
 
Table 1: Advancements of alternative bone cements.
18-26
 
Cement Base Improvement over PMMA Downfalls 
 
Calcium Phosphate 
 
Good biocompatibility, good  
handling properties 
 
Can only be used for nonload 
bearing locations 
 
BisGMA-TEGDMA 
Lower exotherm, reduced 
shrinkage, comparable mechanical 
properties, improved 
biocompatibility 
 
Concern over leachables 
 
  
 
The development of bisGMA-TEGDMA composites have provided significant 
improvements in exotherm, shrinkage, biocompatibility, and mechanical properties in 
comparison to traditional PMMA bone cements.  However, there are still concerns regarding 
the potential of leacheables resulting from the unreacted monomers.  Additionally, 
commercialization of these alternatives has been impacted due to the publication of two 
independent studies indicating that bisGMA composites provided no additional benefit as 
compared to no treatment when used for vertebroplasty.
27, 28
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Siloranes 
 Our group has focused on a relatively new class of ring opening monomers called 
siloranes.  The term silorane was coined as a way to represent monomers, which contain both 
siloxane and oxirane structural functionalities.
29, 30
  Originally developed by 3M-ESPE, 
siloranes were intended for use in dental composites.
31
  These hybrid resins have been shown 
to have enhanced characteristics compared to bisGMA-TEGDMA composites.  The 
incorporation of a siloxane backbone imparts hydrophobicity, while highly reactive 
cycloaliphatic oxiranes enable reduced shrinkage in comparison to methacrylates.
31-33
  
Biocompatibility of the resins has also received excellent ratings; in particular,  cytotoxicity 
and mutagenicity have been reported to be as good as, or better than, that of typical 
methacrylate monomers.
29, 30, 34-36
  Furthermore, siloranes have shown improvements in terms 
of marginal integrity and microleakage, bond strength, and the ability to bond to bone more 
effectively than methacrylate resins.
37-39
  Combined, these qualities highlight the potential 
that siloranes present as a viable bone cement alternative. 
Bone Cement Formulations 
 Bone cement composites are comprised of three major components.  The first 
component is the monomer system (methacrylates or siloranes).  Second is the initiation 
system.  The type of application determines whether polymerization will be initiated by light, 
a chemical, or a mixture of the two.  The final component is the filler.  The filler is added 
with the intention of improving the other mechanical properties of the composite for its 
application.  The selection of filler will depend on the compatibility (e.g. solubility and 
reactivity) with the monomer and the desired properties of the biomaterial formed.  In cases 
5 
 
where the interface between the filler and resin requires an increase in strength, a 
modification may be made to the surface of the filler.    
SilMix and Composite Formulation 
From our previous work with 3M-ESPE and Midwest Research Institute (MRI), two 
monomers (Figure 3) were selected for utilization in our biomaterial, bis[2-(3{7-
oxabicyclo[4.1.0]heptyl})ethyl]methylphenyl silane (PHEPSI, 5) and 2,4,6,8-tetrakis(2-(7-
oxabicyclo[4.1.0]heptan-3-yl)ethyl)-2,4,6,8-tetramethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane 
(CYGEP, 6).
40
 
 
 
 
Figure 3: Silorane monomers: PHEPSI (5) and CYGEP (6). 
 
 
 
The base resin (SilMix) was then prepared by mixing PHEPSI and CYGEP in a 1:1 wt/wt 
mixture.  The currently developed dual-cured composite is then prepared through the 
addition of the other components using a high-speed mixer.  The initiation system is 
comprised of: p-(octyloxyphenyl)phenyliodonium hexafluoroantimonate (PIH, ~1.2 wt% ), 
6 
 
camphorquinone (CPQ, ~0.4 wt%), and ethyl p-dimethylaminobenzoate (EDMAB, ~0.06 
wt%)  added to SilMix (38 wt%).  The filler (60 wt%) is then mixed in, Lamoreaux’s catalyst 
(0.32%) is added and mixed by hand for 30 sec.  For extent of polymerization tests, the 
composite is placed on a glass slide and allowed to polymerize.  Polymerization completion 
was checked at 1 h using a one-pound Gillmore Needle.  Passage of the Gillmore Needle 
Test (GNT) was observed when the sample was able to support the needle for 30 sec, leaving 
behind no visible marks on the sample.   
 The current filler compositions utilized by our group are an yttria alumino-silicate 
glass (DY5) and a barium boroaluminosilicate glass (M12).  These glasses were chosen for 
their ability to provide benefits in mechanical properties, radiopacity, and exothermicity.  For 
both of these glasses, our collaborators have developed surface treatments in order to 
increase the strength of the composites.  The three modifications are (2-(7-
oxabicyclo[4.1.0]heptan-3-yl)ethyl)trimethoxysilane (ECHE-TMS, 7), ((9,9-diethyl-
1,5,7,11—tetraoxaspiro[5.5]undecan-3-yl)methyl)trimethoxysilane (1-TOSU, 8), and (3-(9,9-
diethyl-1,5,7,11-tetraoxyaspiro[5.5]undecan-3-yl)propyl)trimethoxysilane (3-TOSU, 9) as 
seen in Figure 4.  
 
 
  
 
Figure 4: Surface treatment monomers: ECHE-TMS (7), 1-TOSU (8), and 3-TOSU (9). 
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Investigations are underway to determine the optimal combination of filler and surface 
modification for use in our biomaterial.                
SilMix Availability 
Although previously synthesized in the literature, and on an industrial scale, by 3M-ESPE for 
dental composites, the monomers were not commercially available.
30, 31
  Therefore, in the 
development of our silorane-based biomaterial, several hurdles needed to be investigated and 
overcome before any further progress could be made.  First, the components of the bone 
cement needed to be acquired in some fashion, either through purchase, donation, or 
synthesis.  Second, the monomers needed to be of a sufficiently high purity so as to surpass 
the regulatory standards set forth for use as a biomaterial.  Finally, in order to fully examine 
the properties of our biomaterial, a sufficient amount of material needed to be produced using 
an efficient procedure so as to keep costs at a minimum while maintaining the highest quality 
achievable.  Previous work has been performed on both monomers by Crivello et al. which 
provided a synthetic starting point.
41, 42
 
Hydrosilylation Reaction and Mechanism 
 In 1947, Sommer reported the reaction between trichlorosilane and 1-octene in the 
presence of acetyl peroxide (Figure 5), marking the first example of hydrosilylation.
43
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Figure 5: Hydrosilylation of trichlorosilane and 1-octene. 
 
 
 
Hydrosilylation has since been defined as the addition of a hydrosilane containing at least 
one Si-H bond to an unsaturated compound, such as alkenes, alkynes, and carbonyls.
44-46
  
Since its introduction, hydrosilylation has become one of the most versatile methods in the 
production of alkylsilanes.  The efficiency of this reaction has allowed for improvement of 
industrial processes in the production of organosilicones used as adhesives, binders, and 
bioactive compounds.
44, 47
  Additionally, this reaction, when, transition metal-catalyzed, has 
allowed for the development of improved catalytic methodologies important to the field as a 
whole.
48, 49 
The mechanism of hydrosilylation was proposed by Chalk and Harrod decades ago, 
and there is a continued search for a more complete understanding of the reaction.
50
  The 
original Chalk-Harrod mechanism was proposed for the hydrosilylation of an alkene with a 
silane.  Since its introduction, this mechanism has been widely accepted for the use of 
platinum catalysts, but has since been modified for reactions involving Rh, Co, Fe, or Ir 
catalysts.
51-53
  A modified version has been proposed to clarify and address the problems with 
the original mechanism.  It includes a pathway viable for recently developed catalysts as 
depicted in Figure 6. 
 
9 
 
 
Figure 6: Chalk-Harrod (solid) and modified Chalk-Harrod (dashed) mechanisms for the 
hydrosilylation of ethylene with a silane. 
 
 
 
The original Chalk-Harrod mechanism begins with the oxidative addition of the Si-H 
bond to the metal center.
46, 51-54
  Upon addition of the alkene, insertion occurs into the M-H 
bond forming a metal(silyl)(alkyl) complex.  This complex then undergoes reductive 
elimination forming an Si-C bond in the silyl product, while regenerating a metal-alkene 
complex (in the presence of excess alkene).
46, 53
  As research became more focused on the 
reaction, and catalysts became more advanced, a modified pathway was proposed to help 
10 
 
describe the formation of vinyl products.
46, 53, 55, 56
  Similar to the original pathway, the 
modified mechanism begins with oxidative addition and alkene insertion.  It is at the 
insertion step where the pathways diverge.  The modified route was found to proceed with 
insertion into the metal-silyl bond as compared to the metal-hydrogen bond.  At that point, 
the pathway can continue through reductive elimination to produce the desired products or 
diverge through an alternative route.  The alternative pathway proceeds from insertion to -
hydride abstraction, which produces a dehydrogenated vinylsilane.  Then, reductive 
elimination occurs, forming the metal-alkene species.  Through the modified route, the 
dehydrogenated vinylsilane may be produced in addition to the alkyl silane.   
To this point, the determination of which pathway a reaction will pass through has 
mostly been a result of a combination of factors.  The type of alkene and silane utilized each 
plays a role, but most of the research has pinpointed the type of catalyst used to be the major 
factor.  Of the catalysts used, those which have traditionally followed the original Chalk-
Harrod mechanism are those based on the Group 10 metals (Pt, Pd, and Ni).
53
  Alternatively, 
reactions following the modified Chalk-Harrod pathway typically utilize catalysts found in 
Groups 8 (Ir, Ru, and Os) and 9 (Co, Rh, and Ir) of the periodic table. For these reactions, 
both saturated and unsaturated silyl products have been reported, with Group 8 metals 
occasionally producing the latter exclusively.
46, 53
  A high alkene-to-silane ratio has also been 
reported to increase the production of the dehydrogenated product compared to the silyl 
alkane with rhodium catalysts.
52
     
The proposal of the modified Chalk-Harrod mechanism has helped to understand 
several unknown issues, such as the formation of dehydrogenated products, surrounding the 
hydrosilylation of alkenes.  An understanding of the mechanistic pathways for alkenes has 
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allowed for the development of proposals regarding the hydrosilylation of alkynes and 
ketones.
48, 54, 57-60
  Although valuable information has been collected from several 
mechanistic explorations, the Chalk-Harrod model still lacks vital information, such as the 
formation of some side products which include isomerized alkenes.  Similarly, recent reports 
have highlighted the ability of several Ni-, Pd-, and Pt-based catalysts to unexpectedly 
undergo dehydrogenative hydrosilylation.
61
  Thus, while the advancement of the Chalk-
Harrod mechanism currently presents a general idea of how to approach a hydrosilylation 
reaction, there are still several wrinkles which have yet to be ironed out.    
Products and Byproducts of Metal-Catalyzed Hydrosilylation 
The transition metal-catalyzed hydrosilylation of alkenes has become one of the more 
important commercial processes. In recent years, several factors have been identified which 
affect the rate and pathway of the reaction, yield, and composition of the final products.
62
  Of 
the three main components (catalyst, alkene, and hydrosilane) that play a role in the 
formation of the desired compound, the majority of the focus has been placed on the catalyst.  
Over the last half century, platinum-based catalysts have been shown to be the most efficient 
choice for hydrosilylation reactions, even if they have limitations, including regiochemical 
control.  While incredibly useful in the formation of the desired silyl alkane, isomerization 
and dehydrogenation frequently occur as side reactions, thus forming a series of 
byproducts.
63-69
  This problem is not restricted just to platinum complexes, but it has been 
observed in other metal-based catalysts (e.g., rhodium, nickel, palladium, cobalt, and iron).
62, 
70-72
  A generic example of the hydrosilylation of styrene with a trialkylsilane is shown in 
Figure 7 with the potential products.   
 
12 
 
 
Figure 7: Schematic of the hydrosilylation of styrene with a silane results in the production of 
the 15A) anti-Markovnikov -silyl alkane, 15B) Markovnikov -isomerized branched 
alkane, 15C) dehydrogenated -silyl alkene (a vinyl silane), and 15D) alkane products. 
 
 
 
The coupling of a silane with a terminal alkene using a transition metal catalyst 
predominantly forms the anti-Markovnikov -silyl alkane (15A).  In some cases, poor 
regiocontrol will lead to the formation of alternative products.  Isomerization of the silane 
during the reaction forms the branched Markovnikov -adduct (15B), while dehydrogenation 
produces the -silyl alkene (vinylsilane) (15C).  Additionally, in some cases, hydrogenation 
of the alkene has been observed to form the alkane product (15D).
68, 70, 71
  Use of broad-range 
generic catalysts (e.g. Speier’s, Karstedt’s, or Wilkinson’s) in hydrosilylation typically 
provides sufficient reactivity to acquire the anti-Markovnikov product.  There is competition 
with the side reactions due to the lack of regiocontrol (Table 2). 
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Table 2: Reported products formed using generic hydrosilylation catalysts.
62
   
Catalyst Reported Products of Hydrosilylation 
Speier's catalyst (H2PtCl6/i-PrOH) -silyl alkane (A), -silane (B)
 
Karstedt's catalyst 
(Pt2(H2C=CSiMe2OSiMe2CH=CH2) 
-silyl alkane (A), -silane (B) 
Wilkinson's catalyst (RhCl(Ph3P)3) 
-silyl alkane (A), -silane (B), -silyl 
alkene (C), alkane (D) 
 
 
 
Since the hydrosilylation of silanes with alkenes is a vital step in many industrial processes, 
the lack of specific regiocontrol is a problem with the use of generic standard catalysts.  
Therefore, alternative catalysts have been developed from these generic precursors, which 
produce higher regiocontrol to form the desired product.  In some cases, the anti-
Markovnikov product is the major product, while in other reactions the dehydrogenated 
product is formed.
62 
Platinum Derivatives 
The first step for the synthesis of the monomers is to summarize the different 
catalysts used in hydrosilylation reactions.  Since the discovery of platinum complexes as 
catalysts in the addition of silanes to alkenes, the two major focal points of research have 
been on Speier’s (H2PtCl6/i-PrOH) and Karstedt’s (Pt2(H2C=CSiMe2OSiMe2CH=CH2) 
catalysts.  Over recent decades, Karstedt’s complex has emerged as the more trendy choice 
for hydrosilylation reactions due to the higher degree of reactivity.  Unfortunately, while the 
desired anti-Markovnikov product can be formed in yields >90%, competing side reactions 
produce byproducts, such as isomerized alkenes and alkanes.  Additionally, there are 
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numerous reports of formation of a yellow coloration to the solution.  The competing 
reactions and coloration emphasize the need for enhanced catalytic systems. 
The competing side products using the general platinum catalysts made it vital for 
improvements in the reaction and/or conditions and efficient alternative routes.  With the 
already high reactivity and reported yields for Karstedt’s complexes, Markó et al. developed 
a series of N-heterocyclic carbene complexes.   These Karstedt derivatives showed very high 
regioselectivity and chemoselectivity towards the production of the anti-Markovnikov 
product as shown in Figure 8.
65, 66
     
 
 
 
 
Figure 8: Preparation of Karstedt-derived carbene catalyst and use in hydrosilylation. 
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Table 3: Hydrosilylation of terminal alkenes using an N-heterocyclic carbene complex.
65
  
 
 
 
These carbene complexes were successful over a wide range of functionalized terminal 
alkenes as shown in Table 3.  In these reactions, isolated and pure yields were reported, while 
the same reactions run using Karstedt’s catalyst produced a mixture of products and a 
colloidal platinum species.  Interestingly, use of internal alkenes proved to be futile with only 
quantitative amounts of starting material recovered.  Alternatively, Osborn et al. successfully 
derivatized the Karstedt complex through the replacement of the bridging siloxane with a 
series of naphthoquinones.  One example is seen in Figure 9.
73
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Figure 9: Naphthoquinone-derived Karstedt's catalyst. 
 
 
 
Use of these naphthoquinone derivatives in combination with a series of substituted styrenes 
generally produced the  anti-Markovnikov product as the major product.  Unfortunately, in 
many cases a low yield with minor amounts of the isomerized or dehydrogenated products 
was observed.  In summary, the desire to overcome the lack of regiocontrol exhibited in 
platinum catalysts has had mixed results, but the development of catalytic derivatives has 
provided increased control under certain conditions.  
   A large percentage of the reports on platinum catalysts in the literature mention the 
formation of colored bodies (typically denoted as a yellow hue) during the reaction.
63, 65
  
Lewis et al. originally proposed the formation of colloidal platinum complexes, which upon 
formation became the active species in the reaction and were visible as a colored species.  It 
was proposed that the platinum complex is reduced by the hydrosilane to a colloidal species 
at which point the alkene adds directly to the hydrosilane to form the products.  The proposed 
mechanism was based on studies using colloidal Pt, Rh, and other metals along with the 
inhibitory effect of metallic mercury for colloidal metal-catalyzed hydrosilylations.
62
  Lack 
of in situ evidence for the formation of colloids during the catalytically active portion of the 
reaction caused Lewis et al. to further examine their theory.  They later published a more 
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refined study using Karstedt’s catalyst and H2PtCl6 in which they concluded that 
mononuclear and soluble platinum complexes are the catalytic species rather than a colloidal 
complex.  In the formation of the colored bodies, yellowing of the reaction was caused by the 
formation of Pt-Pt and Pt-Si bonded insoluble species at the end of the reaction.
61, 63
  The 
studies by Lewis et al. help to give a better understanding in the still relatively unknown 
Chalk-Harrod mechanism for hydrosilylation reactions. 
A third major, yet less known, catalytic species derived from platinum compounds 
was developed in 1962 by Lamoreaux.
74
  Originally, this catalyst was developed as the next-
generation platinum catalyst to revolutionize the formation of silicon-carbon linkages. It was 
overshadowed by the emergence of Karstedt’s catalyst.  Similar to Speier’s catalyst, 
Lamoreaux’s catalyst is formed from the reaction of chloroplatinic acid hexahydrate in an 
alcohol (1-octanol) to form the platinum complex.  Results show that Lamoreaux’s catalyst is 
a complex mixture of Pt compounds containing aldehyde and ether linkages with both Pt
IV
 
and Pt
II
 species present as determined by mechanistic studies utilizing 
195
Pt NMR 
spectroscopy.
74, 75
  While a highly reactive complex, Lamoreaux’s catalyst has failed to gain 
interest throughout the literature.  With very little usage to this point, few details have been 
reported as to the potential advantages and disadvantages of the complex.  Of these, the most 
notable is the susceptibility of hydrosilylation reactions involving epoxides to gel with the 
use of Lamoreaux’s catalyst.42, 76   
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Rhodium Derivatives 
 In addition to platinum-based catalysts, rhodium has been widely used for a variety of 
hydrosilylation reactions.  In the majority of cases, the catalyst of choice has been 
Wilkinson’s catalyst, Rh(PPh3)3Cl (24), as depicted in Figure 10. 
 
 
 
 
Figure 10: Wilkinson's catalyst 
 
 
 
In reactions utilizing rhodium catalysts, results indicate that more factors than the catalyst 
alone affect the resulting products in hydrosilylations.  Skrydstrup et al. investigated the 
coupling of several terminal alkenes with diphenylated silanes using Wilkinson’s catalyst.77  
The anti-Markovnikov product was obtained in good yields in reactions using varying 
solvents as seen in Table 4.   
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Figure 11: Hydrosilylation of diphenylsilane using Wilkinson’s catalyst. 
 
 
 
Table 4: The solvent effect in hydrosilylations using Wilkinson's catalyst.
77 
Silane Alkene Solvent  Yield (%) 
25 26 THF 81 
25 26 CH2Cl2 71 
25 26 Toluene 85 
25 26 Acetone 17 
25 26 THF + Acetone 50 
25 28 THF 38 
 
 
 
With the exception of acetone, the effect of solvents for these reactions produced minimal 
differences in yield.  In cases where solvents containing a ketone (C=O) were used, 
hydrosilylation of the carbonyl group occurs in the presence of Wilkinson’s catalyst.  
Interestingly, in some cases, reproducibility of previously reported reactions proved 
troublesome.  Specifically, there was a problem with recovery of as little as half of the 
reported yield.  In all of the literature reports, the anti-Markovnikov products were obtained 
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selectively, but it was noted that electronic effects may play a role in the regioselectivity. 
Similar trials, using compounds, such as n-butylacrylate, gave a 46% yield of the 
Markovnikov product.  On the other hand, Li et al. reported only moderate regioselectivity 
using Wilkinson’s catalyst with ethoxysilanes.70, 71  However, derivitization of the rhodium 
catalyst with 2-imidazolium phosphines produced higher regioselectivity (up to 99%) of the 
anti-Markovnikov product as shown in Table 5.   
 
 
 
 
Figure 12: Schematic of imidazolium rhodium complexes.  Reaction conditions: alkene 2.5 
mmol, triethoxysilane 3.0 mmol, 70º, 5 h. R1:R2: 1 (CH3:C2H5), 2 (CH3:C4H9), 3 
(CH3:C6H13), 4 (C2H5:C4H9), 5 (C4H9:C4H9), and 6 (C4H9:C6H13). 
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Table 5: Effect of rhodium complex on hydrosilylation selectivity.
71
  
Catalyst 
(% substrate mol) 
Substrate Conversion (%) 
Selectivity 
(:alkane) 
RhCl(PPh3)3 0.1 Styrene 78.1 81.2:16.5:2.3 
1 (0.02) Styrene 100 89.8:4.1:6.1 
2 (0.02) Styrene 99.4 91.6:3.1:5.3 
3 (0.02) Styrene 96.1 94.9:1.6:3.5 
4 (0.02) Styrene 95.7 96.6:1.9:1.5 
5 (0.02) Styrene 94.5 97.3:1.2:1.5 
6 (0.02)  Styrene 92.1 99.4:0:0.6 
1 (0.005) 1-Hexene 100 99.1:0:0.9 
1 (0.005) 1-Heptene 100 98.7:0:1.3 
1 (0.005) 1-Octene 100 99.0:0:1.0 
1 (0.005)  1-Undene 100 98.8:0:1.2 
 
 
 
To this point, the majority of work has been focused on the optimization of the anti-
Markovnikov silane.  In some cases, the goal may be to produce one of the typical 
byproducts.  The dehydrogenated -silyl alkene or vinylsilane, which may be produced by 
the modified Chalk-Harrod mechanistic pathway for rhodium catalysts, was reported by 
Takeuchi et al.
56
  They focused on the use of vinylsilanes as an alternative to the 
hydrosilylation of alkynes.  The use of a cationic rhodium complex in an excess of styrene 
and various silanes produced the dehydrogenated silyl alkene as the major product in several 
trials as seen in Table 6. 
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Figure 13: Schematic of hydrosilylation using a cationic rhodium complex. 
 
 
 
Table 6: Effect of cationic rhodium complex on hydrosilylation. 
Entry Hydrosilane Time (h) Yield (%)  Product Distribution 35:36:37 
1 HSiEt3 2 91 78:22:0 
2 HSiEt2Me 2 83 51:49:0 
3 HSi(n-Pr)3 2 90 84:16:0 
4
a
 HSi(i-Pr)3 64 81 100:0:0 
5
a
 HSi(t-Bu)Me2 15 85 95:5:0 
6 HSiPhMe2 2 88 12:88:0 
7
b
 HSi(OEt)3 3 67 26:74:0 
a
 Run in 1,2-dichloroethane, 
b
 refluxed in 1,2-dichloropropane.
56
  
 
 
 
Of these trials, only one silane, triisopropylsilane (entry 4), was formed with 100% 
selectivity of the silyl alkene.  The ability to selectively produce the vinylsilane introduces an 
attractive alternative to the hydrosilylation of alkynes.  It also provides useful information as 
to the selectivity of rhodium catalysts.  As with platinum complexes, rhodium-based 
hydrosilylation catalysts have the potential to selectively produce a certain desired product, 
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but still have several problems which need to be investigated (e.g., improved efficiency of 
existing catalysts and recyclability).         
Other Transition Metal Catalysts 
 While the focus of hydrosilylation catalysts has been on the development of platinum 
and rhodium catalysts, a recent trend has been the development of cheaper, more readily 
available metals with better selectivity towards certain products (specifically the anti-
Markovnikov and dehydrogenated products).  Recent advances by Chirik et al. include the 
use of aryl-substituted bis(imino)pyridine iron complexes (38).  They have successfully 
coupled terminal alkenes with hydrosilanes to exclusively produce the anti-Markovnikov 
product in >95% yield.
64, 69
   
 
 
 
 
Figure 14: Iron 38 and bis(dihydrogen) ruthenium 39 complexes used as alternative 
hydrosilylation catalysts.   
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Christ et al. focused on the goal of predominantly producing the vinylsilane through the use 
of a bis(dihydrogen) ruthenium complex (39) with ethylene and HSiEt3 in yields as high as 
97%.
78
  These metals, along with palladium and nickel, to name a few, have gained interest 
as potential alternatives to platinum and rhodium.  Each element provides a unique 
characteristic from affordability and availability to specific regioselective trends in 
comparison to the aforementioned staples.  Current and future research in the field will 
determine if a superior alternative can be developed. 
Mechanism, Products, and Byproducts Wrap Up 
 The versatility of metal catalysts in the coupling of an alkene with a hydrosilane has 
made hydrosilylation a very useful synthetic tool.  The advancement of mechanistic studies 
has provided vital information towards the understanding of the original and modified Chalk-
Harrod mechanism, specifically for reactions utilizing platinum- and rhodium-based 
catalysts.  The use of platinum and rhodium catalysts has provided highly useful syntheses 
for the formation of several extended silanes.  In determining which metal would be of best 
use for a reaction, the general belief is that rhodium-based catalysts are better for less polar 
silanes, while platinum catalysts perform better with more polar silanes.
62
  Consequently, in 
addition to the desired product, many of these reactions produce undesired byproducts.  Both 
the current and historical interests of the field focus on the formation of the anti-
Markovnikov -alkyl silane, but recent advances have included the formation of the 
dehydrogenated -silyl alkene or vinylsilane, most notably through Group 8 based catalysts.  
Improvements in regioselectivity have come through the derivatization of several of the 
generic catalysts and the advancement of cheaper, greener metal alternatives. 
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Previous Studies of Crivello 
Over the last 30 years, the development of silicon-based monomers and oligomers has 
become an interesting field due to their excellent polymerization potential and resulting 
mechanical properties.  Crivello et al. extensively investigated the extension of 
multifunctional silicon-based monomers (siloranes), in particular those containing epoxides, 
through hydrosilylation reactions.
79-81
  The majority of the monomers were prepared starting 
from silanes, compounds containing an Si-H functionality, or siloxanes, compounds 
containing an Si-O-Si functionality.  Crivello et al. investigated photoinitiated cationically 
polymerizable silicon-based monomers containing epoxides.
42
  They synthesized a series of 
multifunctional siloxane monomers and oligomers using the condensation of epoxides 
containing alkenes with siloxanes as seen in Figure 15.   
 
 
 
 
Figure 15: Synthesis of siloxane monomers using Lamoreaux's catalyst. 
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The use of siloxanes as starting materials required the utilization of a platinum-based catalyst 
due to its polar Si-O bond.  Thus, hydrosilylation of the linear, branched, and cyclic 
compounds was performed using the platinum-based Lamoreaux’s catalyst.  Reactions 
involving the use of platinum catalysts will in general follow the Chalk-Harrod mechanism 
(Figure 6, solid line) and can be performed between 0-80 ºC using aprotic solvents.  While 
typically run under an inert atmosphere, there are many times when the reaction may proceed 
under atmospheric conditions.  In the case of the cyclic siloxanes, gelation upon addition of 
the catalyst occurred unless the reaction was performed under nitrogen and extremely dry 
conditions.
42
  It was determined that residual traces of water reacted with the Si-H groups in 
the presence of the platinum catalyst to form an Si-OH group.  These groups would then 
further condense to give a cross-linked polymer network.  To prevent the possibility of 
polymerization, the reagents were distilled, the condenser was fit with a CaCl2 drying tube, 
and the reaction mixture was refluxed through a Dean-Stark trap containing CaH2.  The 
reactions were performed under these conditions and it was possible to successfully 
synthesize several siloxane monomers using the platinum-based Lamoreaux’s catalyst in high 
yields with no reported byproducts.  
 In their subsequent work, Crivello et al. investigated the effect of platinum catalysts 
on reactions containing epoxycyclohexyl groups with compounds containing Si-H moieties.
41
  
The use of platinum catalysts with these monomers resulted in a high percentage of ring-
opening polymerization.  To avoid this result, they explored the use of alternative metal-
based transition catalysts.  It was observed that certain rhodium complexes, in particular 
Wilkinson’s catalyst, were excellent for these particular reactions and were very tolerant to 
various functional groups.  Thus, a series of multifunctional silicon-based epoxides were 
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synthesized from the corresponding silanes and vinyl epoxides with yields ranging from 86-
99% (Figure 16). 
 
 
 
Figure 16: Hydrosilylation of silicon monomers using Wilkinson’s catalyst. 
 
 
 
In addition to cyclohexyl epoxide monomers, it was found that Wilkinson’s catalyst was 
optimal for the hydrosilylation of dialkyl and diarylsilanes.
41
  Furthermore, for the first time 
in hydrosilylation reactions, Crivello et al. reported the use of a cross-linked polystyrene-
bound version of Wilkinson’s catalyst.  This polymer-bound complex was purchased in the 
form of insoluble beads as compared to the unbound powder version.  They noted that the 
change in catalyst substrate exhibited equivalent activity and regioselectivity as the more 
common monomeric powder version.  An additional benefit to the polymer-bound catalyst 
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was the ability of the catalyst to be filtered off after completion of the reaction.  Recovery of 
the catalyst proved to be cost-effective because it could then be used in subsequent reactions 
without loss of reactivity.  In comparison, removal of the powder version is more 
complicated and is typically performed using chromatography with loss of the material.    
 The reports by Crivello et al. helped in the advancement of the field of 
hydrosilylation using epoxy-containing alkenes.  Their work highlighted the potential of 
Lamoreaux’s catalyst as a possible catalyst in the presence of epoxides, albeit under 
extremely dry conditions.  Additionally, these results expanded and developed the use of 
rhodium catalysts, specifically Wilkinson’s catalyst, as an excellent alternative for reactions 
involving epoxides without the detrimental ring-opening side reactions. 
Results and Discussion 
For the development of our biomaterial, it was essential to acquire the two silorane 
monomers.  Both monomers were unavailable commercially, thus it was essential for the 
development of synthetic procedures.  Therefore, suitable scale up syntheses were developed 
using work conducted previously by Crivello et al. as a roadmap.
41
 
 
PHEPSI and Polymer-bound Wilkinson’s catalyst 
 A scale-up synthesis of PHEPSI was developed, and the overall reaction is depicted 
in Figure 17.  
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Figure 17: Synthesis of the silorane monomer, PHEPSI. 
 
 
 
Attempts at optimizing the hydrosilylation of methylphenylsilane and 4-vinyl-1-cyclohexene-
1,2-epoxide are given in Table 7.   
 
 
 
Table 7: Attempts to optimize PHEPSI reaction conditions.  
Entry MPS (g) Wilkinson's Catalyst Supplier Temp Time % Yield 
1 1.2 g Styrene-divinylbenzene bound  Alfa Aesar 90° 24 h  0 
2 1.2 g Styrene-divinylbenzene bound  Alfa Aesar 90° 48 h 0 
3 2.4 g Powder, 97% Alfa Aesar 95° 24 h  42 
4 9.7 g* Powder, 97% Alfa Aesar 95° 24 h  33 
5 19.4 g* Powder, 97% Alfa Aesar 100° 24 h  67 
6 19.4 g* Powder, 97% Alfa Aesar 95° 18 h 66 
7 19.4 g* Powder, 99% Strem 95° 18 h 45 
8 9.7 g  Powder, 99% Strem 100° 24 h  63 
9 19.4 g Powder, 99% Strem 95° 24 h  46 
* indicates side-by-side reactions run and combined after IR spectra were collected. 
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The initial attempts of the coupling of methylphenylsilane to vinylcyclohexene epoxide 
utilized a styrene-divinylbenzene polymer-bound Wilkinson’s catalyst.  These trials used a 
reaction temperature of 90 ºC for 24 h.  The reaction progress was monitored using IR 
spectroscopy.  Since the Si-H peak of methylphenylsilane is found uniquely at 2160 cm
-1
, it 
was used to monitor the reaction progress.  Disappearance of this peak indicated the starting 
silane had been consumed.  After 24 h, the peak was still present.  With subsequent heating 
for an additional 24 h (trial 2), the peak was still observed.  After repeated attempts, no 
change in the reaction was observed.  With these negative results, focus was placed on the 
use of an alternative catalyst. 
Powder Monomeric Wilkinson’s Catalyst 
Unable to reproduce the published procedure, we switched to the generic crystalline 
powder form of the catalyst instead of the polymer-bound version.
41
  The IR spectrum 
resulting from heating of the reaction to 95 ºC for 24 h (trial 3) showed the absence of the 
peak at 2160 cm
-1
 using the powdered Wilkinson’s catalyst.  This modification resulted in the 
desired conditions for successful formation of the silorane.  With a successful procedure 
underway, several factors were investigated to find the optimal conditions for the production 
of PHEPSI.       
The factors which were investigated included the temperature, time, and scale of the 
reaction.  Primary trials tested the effect of heat on the reaction versus product formation 
(Table 7).  It was found that heating at 90-100 °C was required for complete conversion, with 
the optimal conditions from those reactions with temperatures between 95-100 °C resulting in 
yields of 66 and 67%, respectively.  Secondly, reaction time was examined.  During the 
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trials, it was observed that very little visible change occurred in the reaction after ~15-20 h of 
heating.  IR spectra were collected at different time periods and compared to a spectrum 
collected after 24 h of heating.  The absence of the Si-H peak at 2160 cm
-1
 was observed as 
early as 18 h, thus indicating completion of the reaction.  In a comparison of trials 5 (24 h) 
and 6 (18 h), no significant change in yield was observed.  Therefore, these results indicated 
that the optimal conditions included heating the reaction mixture at 95-100 °C for 18-24 h 
utilizing the crystalline powder version of Wilkinson’s catalyst.           
PHEPSI Scale-Up 
If these monomers are to be used as a commercial biomaterial, a sizable quantity of 
resin is required for testing ex and in vivo; therefore, a reproducible scale-up of the reaction 
became the next essential task.  Preliminary test reactions were run on a small scale (1.2 g of 
methylphenylsilane) using the polymer-bound catalyst (Table 7).  With the use of the 
powdered Wilkinson’s catalyst (Alfa Aesar, 97% purity), the reaction scale was doubled in 
hopes of producing enough material to fully explore purification routes.  PHEPSI was 
synthesized and isolated in a 42% yield after purification.  The scale was again increased to 
9.7 g of methylphenylsilane (side-by-side reactions of 4.8 g and combined before 
purification), but resulted in a lower yield (33%).  Again, side-by-side reactions were run, 
and this time with 9.7 g (19.4 g combined total) resulting in an isolated yield at 67%.  In 
order to investigate the differences in suppliers of the catalyst, a Strem version was run on 
the same scale.  However, this change produced a significant loss of product (or production 
of byproduct) with a yield of 45%.  While the set-up of side-by-side reactions was working, 
the assembly of two reactions is not conducive to scale-up.  A single 19.4 g reaction batch 
(entry 9) was run and resulted in a 46% yield.  This result indicates that the hydrosilylation of 
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PHEPSI has the potential to be scaled to much larger sizes without significant loss of yield.  
It is interesting to note that a yield of 63% was obtained utilizing the Strem-manufactured 
Wilkinson’s catalyst on a 9.7 g scale.  The large difference in yield between the reaction 
scales may be due to purification as a principal factor in the loss of product during the 
process.   
 The ability to increase the reaction scale in the synthesis of PHEPSI became an 
essential task as the demands for significant quantities of the monomer rose.  While a loss of 
yield was reported for similarly sized batches using different catalyst suppliers, comparative 
yields for reactions indicate that this loss of product may be the result of the purification of 
the product as opposed to catalyst reactivity.  At this point, it is believed that further scale-up 
of the PHEPSI reactions should be successful.    
PHEPSI Purification 
The previously reported purification of PHEPSI utilized a standard organic chemistry 
workup (e.g., filtration of the catalyst, followed by the removal of solvents and unreacted 
starting materials under reduced pressure).
41
  In our attempts using this procedure, we were 
unable to remove either the catalyst or any unreacted starting materials via filtration and 
concentration under reduced pressure.  Additionally, due to the viscosity of the crude 
material, residual solvents were trapped in the thick liquid as determined by 
1
H NMR 
spectroscopy.  Thin layer chromatography (TLC) was used to determine the presence of any 
UV detectable compounds and their potential separability.  The presence of two distinct spots 
(Rf 0.21 and 0.47, solvent: 10% ethyl acetate‒hexanes) led to the determination that column 
chromatography would be a suitable means of purification.   
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Due to the viscosity of the crude material, the residual solvents were successfully 
removed via vacuum.  Dilution of the crude reaction material in hexanes, which was 
followed by elution using a solvent gradient that ranged from hexanes to 10% ethyl acetate‒
hexanes, provided the appropriate separation of the two UV detectable bands on the column.  
Collection of the bands provided important information about the reaction.  It was 
determined that a combination of unreacted vinylcyclohexene epoxide and an unidentified 
byproduct were present in the first band at Rf 0.47, and PHEPSI, the product, as a colorless, 
viscous liquid at Rf 0.21 was the second material.  It is of note that fractionation between the 
bands shows bleeding of the two bands in varying amounts.  An increase in the volume of 
hexanes prior to adjusting the polarity of the mobile phase provided more separation, but 
only to a small extent.  Even through various trials, isolation of pure PHEPSI from the 
remaining epoxide and byproduct was not achieved.  Additionally, further attempts to 
separate unreacted epoxide from the byproduct were unsuccessful.  As expected, Wilkinson’s 
catalyst remained at the top of the column.  This successful isolation of the products proved 
to be an important step in the development of a biomaterial, as it produced PHEPSI in high 
purity.  Through this process it was determined that the ideal purification of PHEPSI is via 
column chromatography utilizing a solvent-gradient starting with 100% hexanes to 10% 
ethyl acetate‒hexanes.   
PHEPSI Byproduct 
 As discussed previously, rhodium-catalyzed hydrosilylation reactions have been 
shown to produce several products.
56, 62, 70, 71
  The synthesis of PHEPSI followed this trend, 
as additional products were formed.  To gain a better understanding of the reaction, 
identification of the byproduct was investigated.  Purification of the material allowed for the 
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separation of PHEPSI from the additional products, but the mixture of the byproducts and 
unreacted monomer could not be further separated.  Analysis of the mixture by 
1
H and 
13
C 
NMR spectroscopy allowed for the formulation of what may comprise the mixture.  The 
1
H 
NMR spectrum contained various peaks which cannot be attributed to methylphenylsilane, 4-
vinylcyclohexene-1,2-epoxide, or PHEPSI.  Of the peaks, those of interest included the 
presence of unique peaks between 0.00-0.40, 3.15-3.25, 5.15-5.25, and 7.50-7.60 ppm 
(Figure 18). 
 
 
 
 
 
 
 
 
 
 
 
 
  
3
5
 
 
Figure 18: 
1
H NMR spectra of 4-vinylcyclohexene-1,2-epoxide (top), PHEPSI byproduct (middle), and PHEPSI (bottom). 
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This combination can be attributed to an additional PHEPSI-like or alternate compound due 
to the distinct similarities in the spectrum.  For the 
13
C NMR spectrum, the introduction of 
peaks between 20-40 ppm (up to an additional 10 peaks) and above 100 ppm (up to an 
additional 8 peaks between 113-133 ppm) further supports the hypothesis of a PHEPSI-like 
product.  Additionally, peaks (vinyl alkene from the cyclohexene epoxide, multiplets at 4.90-
5.00 and 5.60-5.75 ppm) appeared in an altered splitting pattern to that of the unreacted form 
(multiplets 4.85-4.95 and 5.45-5.60 ppm).  With the use of the rhodium-based Wilkinson’s 
catalyst, the general thought is that the reaction would proceed through the modified Chalk-
Harrod pathway (Figure 6, dashed line).  Therefore, it seems likely that a dehydrogenated 
vinyl silane may be produced.  In the case of PHEPSI, where a double hydrosilylation takes 
place, there is the possibility of two vinyl products being formed as seen in Figure 19. 
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Figure 19: Potential byproducts in the hydrosilylation of PHEPSI include vinyl and divinyl 
derivatives. 
 
 
 
The introduction of peaks in the 5-6 ppm range of the 
1
H NMR spectrum and above 110 ppm 
in the 
13
C NMR spectrums may be attributed to the presence of the alkenes, while the 
additional aromatic peaks support the presence of a phenyl-bearing compound.  
Unfortunately, the need to run the reaction using a molar excess of the cyclohexene epoxide 
ensures the presence of unreacted monomer at the conclusion of the reaction.  Optimal 
reaction conditions have not allowed for full characterization of the byproducts to this point.  
In addition to formation of the dehydrogenated vinyl silanes, other products may potentially 
be formed, including -silane or any combination of or dehydrogenated products. 
PHEPSI Optimization Recap 
 In the development of the first of two silorane monomers for use as a potential 
biomaterial, PHEPSI was synthesized using the hydrosilylation of methylphenylsilane with 
4-vinylcyclohexene-1,2-epoxide using a powdered form of Wilkinson’s catalyst.  When a 
polymer-bound catalyst failed to produce the monomer, the crystalline version was employed 
with improved results.  Continued modifications to these procedures led to the determination 
of the optimal conditions, including heating of the reaction to 95-100 °C for 18-24 h.  
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Furthermore, the use of a solvent gradient ranging from 100% hexanes to 10% ethyl acetate‒
hexanes with column chromatography allowed for the best separation of the product from 
most other components in the crude material.  This combination of modifications led to the 
overall synthesis of PHEPSI in usable yields as high as 67%. 
Optimization of CYGEP 
During the ongoing optimization of PHEPSI, attempts to identify the ideal route for 
the synthesis of CYGEP were running concurrently.  The first published synthetic procedure 
of CYGEP by Crivello et al. reported the use of Lamoreaux’s catalyst (LMC) under 
extremely dry conditions in the hydrosilylation of 2,4,6,8-tetramethylcyclotetrasiloxane 
(TMCTS) and 4-vinyl-1-cyclohexene-1,2-epoxide as depicted in Figure 20.
42
  
 
 
 
Figure 20: Schematic of the synthesis of the silorane monomer CYGEP. 
 
 
 
Therefore, the next step was to review literature for the synthesis of LMC. 
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Development of Lamoreaux’s Catalyst 
In the early 1960’s, the scope of knowledge concerning the catalysis of 
hydrosilylation reactions was still in its infancy.  At the time, catalysis of such reactions was 
somewhat limited to organic peroxides and palladium- or platinum-containing materials, 
each with its own drawbacks.  Generally, the most useful reagent was that of chloroplatinic 
acid in a short-chained alcohol (e.g., Speier’s catalyst dissolved in isopropyl alcohol).  While 
Speier’s was very versatile in terms of reagent variations, its major drawbacks included 
potential ineffectiveness at low concentrations, insolubility in many organic materials, and 
the tendency to become poisoned by external influences.
74
    
 In an effort to develop a more reliable catalytic option, Lamoreaux introduced a 
platinum complex derived from the reaction of chloroplatinic acid hexahydrate and octanol in 
1962 as seen in Figure 21.
74
   
 
 
 
 
Figure 21: Synthesis of Lamoreaux's catalyst. 
 
 
 
A solution of octanol and chloroplatinic acid in a 7:1 mole ratio was heated to 70 °C for 40 h 
at 25 mmHg and produced a platinum chloride complex with aldehyde and ether linkages 
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derived from octanol.  Lamoreaux reported the use of the platinum complex as a 
hydrosilylation catalyst for several silicon-containing compounds.
74
  Included was the 
synthesis of ester-containing silanes and saturated cyclic silanes (Figure 22). 
 
 
 
 
Figure 22: Schematics of Lamoreaux's catalyst catalyzed hydrosilylations. 
 
 
 
The resulting complex utilized less rigorous reaction conditions, demonstrated good 
efficiency at low concentrations, improved degree of solubility in organic solvents, and 
improved resistance to platinum catalyst poisons.  Therefore, the first step in our synthesis of 
CYGEP was to generate our own version of Lamoreaux’s catalyst as we were unable to 
obtain it commercially.  The original procedure by Lamoreaux called for a pressure of 25 
 41 
 
mmHg.  We used a pressure of 0.01 mmHg, so we lowered the temperature to 50-55 °C and 
heated the reaction mixture for 42-44 h. The reaction conditions are listed in Table 8.   
 
 
 
Table 8: Lamoreaux’s catalyst formulations. 
Entry  H2PtCl6 (g) Octanol (mL) Temp (°C) Time (h) 
1 1.01 2.1 50-55 40 
2 1.00 2.1 70 40 
3 1.00 2.1 50 40 
4 1.00 2.1 70 48 
5 2.14 4.5 55 42 
6 2.14 4.5 50-55 42 
7 0.57 1.5 55 42 
8 2.15 4.5 55 42 
9 2.89 6.0 55 42 
10 2.43 5.5 50-55 42.5 
11 2.51 5.5 55 42 
12 2.49 5.5 55 42 
13 2.52 5.5 55 42 
14 2.53 5.5 55 43 
15 2.50 5.5 55 43 
16 2.50 5.5 55 (80 after 30 h) 43 
17 2.52 5.5 55 43 
18 2.55 5.5 55 43 
 
 
 
The resulting complex was a dark black solution with a consistency similar to that of olive 
oil.  IR and 
1
H NMR spectra were collected for the starting materials, starting mixture, and 
final product.  The OH peak of octanol (signal variess between 2.5 and 6.0 ppm typically) 
was used in both spectra to compare the different batches.  Subsequent attempts to reproduce 
the complex were successful, but it was observed that heating to above 70 °C for a fraction of 
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the reaction time (entry 16) would result in removal of a significant amount of the octanol as 
determined by 
1
H NMR spectroscopy.  The loss of octanol would result in a solution with 
less viscosity which was accompanied by a difference in reactivity when the catalyst was 
used in polymerization tests as determined by the 1-lb Gillmore needle test.  Additionally, the 
use of chloroplatinic acid which had been exposed to air would result in a final product with 
a granular paste-like texture and lowered reactivity.  In an effort to prevent the loss of 
reactivity, the solution was stored under argon at temperatures <10 °C.  It was observed that 
even with meticulously dry conditions, reproducibility of the reaction was only successful up 
to 10 days after opening the new chloroplatinic acid.      
 Repeated trials in the preparation of Lamoreaux’s catalyst resulted in optimal reaction 
conditions with the heating of chloroplatinic acid hexahydrate and octanol to 50-55 °C for 
42-44 h at a pressure of 0.01 mmHg.  In order to obtain the highest reactivity, storage of 
chloroplatinic acid under argon between 0 to 10 °C is needed for no more than 10 days post 
initial opening of the container of chloroplatinic acid.   
Reproduction of the Crivello Synthesis 
The synthesis of CYGEP originally reported by Crivello et al. required the addition of 
two drops of Lamoreaux’s catalyst to the reaction mixture at room temperature.42  The 
solution was then heated to 50-55 ºC for 3 h, followed by standing at room temperature 
overnight.  An IR spectrum was then collected to monitor the completion of the reaction by 
the disappearance of the Si-H peak at 2100 cm
-1
.  As determined by Crivello et al., this 
procedure was only successful when the reaction was run under nitrogen and meticulously 
dry conditions.  These conditions could be accomplished by using freshly distilled reagents, 
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adding a CaCl2 drying tube, and refluxing the solution through a Dean-Stark trap containing 
CaH2.  In the instances where extreme care was not taken, gelation would occur upon 
addition of the catalyst to the reaction mixture.  This effect was attributed to residual water 
reacting with the catalyst to form further condensable Si-OH groups resulting in cross-linking 
of the monomeric materials.
42
  Initial attempts to reproduce the results were followed 
according to a scaled-down version of the reported procedure, but with very different 
outcomes as shown in Table 9.   
 
  
4
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Table 9:  Formulations in the synthesis of CYGEP. 
Trial 
2,4,6,8-
TMCTS (g) Temp Time Lamoreaux Catalyst 
Temp at catalyst 
addition CH3CN Yield (%) Polym. 
1 6.0 g reflux 2 h 1 drop RT  -  0 Yes 
2 12.0 g reflux 2 h 1 drop 0 °C  -  0 No 
3 24.0 g reflux 2 h 2 drops 0 °C  -  0 Yes 
4 12.0 g reflux 2 h 1 drop 0 °C  -  0 Yes 
5 12.0 g reflux 2 h 1 drop 8 °C  -  21 No 
6 12.0 g reflux 2 h 1 drop 16 °C  -  0 Yes 
7 24.0 g* reflux 2 h 1 drop 8 °C  -  56 No 
8 12.0 g reflux 2 h 1 drop 8 °C  -  0 Yes 
9 12.0 g reflux 2 h 0.3 mL (50% solution in toluene) 6 °C  -  0 Yes 
10 6.0 g 70 °C 30 min 10 drops (0.50% solution in toluene) 70 °C 0.27 mL 17 No 
11 24.0 g* 70 °C 30 min 0.5 mL (0.5% solution in toluene) 70 °C 0.54 mL 49 No 
12 24.0 g* 70 °C 30 min 0.5 mL (0.5% solution in toluene) 70 °C 0.54 mL 63 No 
13 12.0 g 70 °C 30 min 0.5 mL (0.5% solution in toluene) 70 °C  -  0 Yes 
Polym. = polymerization of the solution after the addition of the catalyst, but prior to purification.  Yields were recorded as isolated 
products (* indicates side-by-side reactions were run and combined after IR collected).  Reactions were run in anhydrous toluene with 
minimal outside light. 
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The addition of Lamoreaux’s catalyst (1 drop) to the reaction mixture at room temperature of a 6 
g batch (trial 1) resulted in an extremely exothermic reaction that caused immediate 
polymerization of the materials to a rock-like material.  To slow down the rate of reaction and 
prevent instantaneous polymerization, the system was cooled to 0 ºC prior to the addition of the 
catalyst.  No change was observed upon catalyst addition (trial 2), and the resulting pale yellow 
solution was then heated to 50 ºC for 3 h before being allowed to stir at room temperature for 16 
h.  Since the Si-H peak of the starting material (TMCTS) is at 2100 cm
-1
, it was used to monitor 
the reaction progress using IR spectroscopy.  Purification was attempted using column 
chromatography (silica gel; solvent:  10% ethyl acetate‒hexanes), but no material was recovered 
from the column.  The procedure was repeated with 2 drops of catalyst (trial 3), ultimately 
resulting in polymerization to a white solid.  Trial 2 was repeated, but this time it resulted in 
gelation occurring 30 min post catalyst addition.  Subsequent trials (5 and 6) were concurrently 
run at 8 and 16 ºC, respectively.  After stirring for 16 h at room temperature, an IR spectrum was 
taken for both reactions.  The Si-H peak was absent in the spectrum of trial 5, but still present in 
the spectrum of trial 6.  Trial 6 was then cooled to 8 ºC where an additional drop of catalyst was 
added, and the solution stirred at room temperature.  After 3 h, gelation occurred for trial 6.  Trial 
5 was then purified by column chromatography (silica gel; solvent:  10% ethyl acetate‒hexanes) 
to obtain CYGEP in a 21% yield.  Unfortunately, reproducibility was difficult among the ensuing 
trials as approximately 75% of attempts resulted in polymerization.  Since reproducibility was an 
issue, an alternative procedure was needed. 
Aoki Procedure 
A synthesis of organopolysiloxanes or organosilanes bearing an epoxy functionality 
without undesired polymerization or gelation occuring was reported by Aoki.
82
  In his study, he 
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examined hydrosilylation reactions with alkenyl-group bearing epoxides in the presence of a 
cyano group-bearing compound, preferably acetonitrile or benzonitrile (Figure 23). 
 
 
 
 
Figure 23: Reaction of trimethoxysilane and 4-vinylcyclohexene-1,2-epoxide in the presence of 
benzonitrile. 
 
 
 
At a minimum of 10 ppm of platinum, an exothermic reaction occurred upon catalyst addition, 
but proceeded without gelation.  Analysis by GPC, and IR and 
1
H NMR spectroscopies identified 
the resulting material to be an epoxy-containing organopolysiloxane.  The use of volatile nitriles 
allowed for their removal, along with the reaction solvents under reduced pressure.   
Alternative Approach to CYGEP 
Unable to routinely prevent polymerization for the synthesis of CYGEP, a modified 
procedure of Aoki was utilized.  The reaction was heated to 70 ºC for 30 min with the inclusion 
of 0.27 mL of acetonitrile (trial 10).  A vigorous exothermic reaction occurred upon the addition 
of Lamoreaux’s catalyst (10 drops of a 0.5% solution in toluene), which raised the temperature to 
~130 ºC.  After ~3 min, the bubbling subsided, and the solution was allowed to cool back down 
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to 70 ºC where it was heated for an additional hour.  The absence of the Si-H peak at 2100 cm
-1
 
in the IR spectrum indicated completion of the reaction.  The crude material was purified using 
column chromatography (silica gel; solvent:  10% ethyl acetate‒hexanes) to give CYGEP as a 
clear, viscous liquid in a 17% yield.  Ensuing trials were scaled up resulting in increased yields.  
The improvement in yield to 63% using 0.5 mL of a 0.5% solution in toluene of the catalyst per 
reaction is given in Table 9, trial 12.          
In summary, any attempts to synthesize CYGEP without acetonitrile resulted in 
exothermic polymerization of the starting materials to a rock-like material upon the addition of 
the catalyst.  This result indicated the importance of acetonitrile in this procedure and 
substantiated Aoki’s results that the addition of a cyano-group bearing compound allowed for the 
successful conversion to the silorane without the undesired gelation.  
Commercial Lamoreaux’s Catalyst (Platinum Octanal/Octanol Complex) 
 In the optimization of the synthesis of CYGEP, catalysis of the reaction was limited to 
the use of Lamoreaux’s catalyst.  During this investigation, a second version of the catalyst 
became available.  A commercially available platinum octanal/octanol complex was found to be 
available through Gelest.  Upon receipt of the octanal/octanol complex, several reactions were 
run using the commercial complex in place of the synthesized Lamoreaux’s catalyst (Table 10).  
For these reactions, the optimal conditions were used so as to give a comparison between the two 
catalysts.  In all instances, polymerization was not observed upon addition of the commercial 
catalyst.  The vigorous exothermic reaction occurred as was expected, and the temperature 
increased to ~130 °C.  Therefore, the effects of concentration and other conditions were 
investigated. 
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Table 10: Optimization of CYGEP with platinum octanal/octanol complex. 
Entry TMCTS (g) Lamoreaux Catalyst Acetonitrile Yield (%) Polym. 
1 24.0 g* 1 mL (1% solution in toluene) 0.54 mL 38 No 
2 24.0 g* 1 mL (0.64% solution in toluene) 0.50 mL 17 No 
3 12.0 g 1.5 mL (0.50% solution in toluene) 0.50 mL 34 No 
4 12.0 g 1 mL (1.5% solution in toluene) 0.50 mL 33 No 
5 12.0 g 1 mL (1.75% solution in toluene) 0.65 mL 41 No^ 
6 23.8 g 1 mL (1.62% solution in toluene) 1.2 mL 27 No^ 
7 23.8 g 1 mL (3.14% solution in toluene) 1.2 mL 26 No^ 
8 12.0 g 1 mL (3.14% solution in toluene) 0.6 mL 46 No^ 
9 12.0 g 1 mL (1.91% solution in toluene) 0.6 mL 40 No^ 
10 24.0 g* 1 mL (0.79% solution in toluene) 0.54 mL 24 No 
11 12.0 g 1 mL (0.79% solution in toluene) 0.54 mL 37 No 
12 12.0 g 1 mL (0.79% solution in toluene) 0.54 mL 40 No 
All reactions were heated to 70 ºC for 30 min at which point the catalyst was added.  Polym. = 
polymerization of the solution after the addition of the catalyst, ^ indicates the formation of a 
highly viscous liquid which was insoluble in hexanes. 
 
 
 
 A difference in reactivity was observed immediately in those reactions using the Gelest 
complex because it required either larger volumes or higher concentrations of solutions for the 
reaction to occur.  Use of a 1% solution of the Gelest catalyst required the addition of 1 mL of 
the catalyst (entry 1) as compared to the use of only 0.5 mL of a 0.5% (Table 10, entry 12) 
solution with the synthesized catalyst.  Upon purification of the crude material, this formulation 
proved to show other differences as well.  In entry 1 of Table 10, 1-mL of the 1% Gelest 
complex resulted in a 38% yield of CYGEP.  In addition to a decreased yield, an additional peak 
was observed in the 
1
H NMR spectrum at 4.6 ppm.  In trials where the peak at 4.6 ppm was 
present, additional shoulders or side bands emerged out of the Si-CH3 peak at 0.0 ppm.  As seen 
in Table 10, subsequent reactions were performed using varying concentrations of the catalyst in 
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hopes of finding the most favorable range in which no polymerization occurred while producing 
the highest yield.   
 In an effort to compare the reactivity of the catalysts using similar concentrations, a trial 
was run using the Gelest catalyst at a 0.50% weight percent solution in toluene.  At the same 
weight percent, the reaction involving the Gelest catalyst required 1.5 mL to produce the 
vigorous exothermic reaction, which is observed in the formation of CYGEP.  Under the same 
conditions, the synthesized version of Lamoreaux’s catalyst required only 0.5 mL for 
completion.  Additionally, upon purification, the 
1
H NMR spectrum of the Gelest batch (entry 3) 
had the additional peak at 4.6 ppm, whereas the peak was absent in the trials using the 
synthesized catalyst.  A comparison of the yields also favored the use of the synthesized catalyst 
with yields <63% as compared to the 34% yield obtained using the Gelest catalyst.  The weight 
percent of the Gelest complex was then increased in hopes of increasing monomer production.  
The amount of catalyst was held constant at 1-mL while the solution concentrations were 
increased.  Trials 4 through 9 were run with weight percents from 1.50 to 3.14%, resulting in 
yields of 41% (trial 5, 1.75% catalyst) and 46% (trial 8, 3.14% catalyst).  The increase in catalyst 
concentration required for production of product seemed to correlate with the appearance of the 
peak at 4.6 ppm (Table 11). 
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Table 11: Comparison of catalyst concentration and volume to peak intensities in CYGEP using 
the Gelest catalyst. 
Concentration (%) Volume (mL) 
Peak Intensity 
(a:b:c) 
0.50 1.5 1:12.6:4.9 
0.65 1.0 1:33.4:17.1 
1.62 1.0 1:75.5:40.3 
1.75 1.0 0:151:78.5 
1.91 1.0 1:60.4:36.6 
3.14 1.0 1:302:164 
Newly observed peak (a, 4.6 ppm) compared to known investigated signals for CH-O of 
epoxides (b, 3.1 ppm) and Si-CH3 (c, 0.0 ppm). 
 
 
 
At higher catalyst concentrations, the peak was either faintly visible or absent.  However, at 
lower concentrations, the peak was present. Secondly, use of the Gelest catalyst resulted in 
byproducts as determined by TLC (solvent: 10% ethyl acetate‒hexanes) of the crude material.  
Finally, at catalyst concentrations greater than 1.50%, a small fraction (~15-20%) of the resulting 
crude material had a higher viscosity than is observed at lower concentrations.  In preparation for 
column chromatography, the crude material was dissolved in hexanes, but the higher viscosity 
liquid was observed because it was insoluble in hexanes.  On the other hand, the residue was 
readily soluble in more polar solvents, such as ethyl acetate and acetone.  This residue was 
collected and the solvents were removed under vacuum.  Spectra (
1
H and 
13
C NMR) were 
collected for the crude residue.  In a comparison with the corresponding spectra for the purified 
material from the reaction, those peaks associated with pure CYGEP correlated with the crude 
material.  In the 
1
H spectrum of the residue, several extra signals were also present, which 
included peaks at 0.2 and 4.6 ppm (included in the catalyst investigation), at ~5.0 and 5.7 ppm 
(potentially unreacted vinyl epoxide), 0.9 ppm (multiplet arising out of the multiplet at 0.8 ppm), 
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and 1.0 ppm (doublet).  Of these, the latter two signals were unique to any previously observed 
spectral abnormalities.  Interestingly, it was noted that as time elapsed (several days), the ratio of 
these unique peaks decreased in comparison to other signals in the spectrum.  After more than a 
week, a spectrum was collected and the absence of the unique peaks was noted.  A minimal 
amount of hexanes was added to the sample, and the presence of the unique peaks returned.  A 
third spectrum was collected after a second addition of hexanes with the peaks overpowering 
those peaks representative of CYGEP.  Thus, the latter unique peaks in the residue were 
determined to be residual hexanes, which were not removed via the vacuum pump.  Comparison 
of the 
13
C NMR spectrum of the purified and crude residue resulted in two new peaks (-0.4 and 
1.5 ppm).  However, with the exception of 25.3 ppm, all the peaks typical of CYGEP were 
doubled and split.  The shifts of the signals in the same order as CYGEP allows for the 
determination that the residue has very close structural similarities to that of CYGEP.  However, 
additional investigations needed to be undertaken to obtain a better understanding of the residue. 
Analysis of the NMR Signal at 4.6 ppm 
 The substitution of the synthesized catalyst for the commercially available Gelest catalyst 
in the synthesis of CYGEP resulted in the presence of a new peak in the 
1
H NMR spectrum.  The 
broad peak appeared at 4.6 ppm and varied in intensity from trial to trial.  It was noted that the 
peak intensity generally correlated with the concentration of Lamoreaux’s catalyst used in the 
reaction.  In comparison to the starting materials, a similar observation was noted with the Si-H 
peak at 4.65 ppm in the spectrum of 2,4,6,8-tetramethylcyclotetrasiloxane.  As mentioned 
previously, visible shoulders or side bands emerged (at ~0.1 ppm) from the Si-CH3 peak at 0.0 
ppm in those trials in which the peak at 4.6 ppm was present.  A comparison was then made of 
the 
13
C NMR spectra for CYGEP with and without the peak at 4.6 ppm.  This sample included 
 52 
 
all signals for pure CYGEP, but with additional daughter-type peaks.  The peaks were present at 
-1.2 and 0.9 (-0.8), 13.6 (13.9), 29.1 (29.2), and 29.6 (29.8) ppm in a low proportion to those 
peaks in parentheses.  These additional peaks in both the 
1
H and 
13
C NMR spectra display 
similarities to both CYGEP and unreacted TMCTS.  Additionally, the presence of a small peak 
at 2100 cm
-1
 in the IR spectrum is observed in these reactions.  The observations seemed to 
correlate with the effect of catalyst concentration, possibly leading to incomplete conversion of 
all four Si-H bonds of the epoxy substituent (Figure 24). 
 
 
 
 
Figure 24: Trifunctional monomer potentially formed due to incomplete conversion of all four 
Si-H bonds in the hydrosilylation of CYGEP. 
 
 
 
CYGEP Scale Up 
 As in the case of PHEPSI, the ability to produce CYGEP in large quantities was 
important if this co-monomer mixture would be used as a biomaterial.  After the successful 
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synthesis of CYGEP was accomplished, side-by-side reactions were run on 12.0 g reactions.  
Upon reaction completion, these batches were combined and purified together resulting in yields 
of up to 63%.  With the continued success of the procedure, no further scale-up trials were 
attempted using the prepared catalyst.   
 With the acquisition of the catalyst from Gelest, reactions were run using similar 
conditions and scale as used for the prepared catalyst.  Unable to achieve comparable yields, the 
procedures were modified to improve upon the results.  In lieu of side-by-side reactions, a single 
23.8 g reaction was run resulting in recovery of only 27% of the desired product.  Repeated trials 
resulted in no improvement of the yield, and attempts at any further scale-up were abandoned.  
On the other hand, a general improvement was observed in the instances where the reactions 
were not combined for purification.  Rather, they were purified individually on 12.0 g scales 
obtaining yields in the 40-46% range.  Even though increased reaction size generally resulted in 
decreased yields, the scalability of the reaction has been accomplished in reactions up to 23.8 g.    
CYGEP Purification 
Purification of CYGEP according to previously reported procedures was achieved first by 
the removal of solvents and excess epoxide under vacuum.
42
  In our attempts using this 
procedure, we were unable to remove the catalyst and unreacted starting materials.  In addition, 
the residual solvents remained due to the viscosity of the crude material, which included 
unidentified byproducts.  The ability to purify PHEPSI by column chromatography drove the 
decision to utilize the process in the purification of CYGEP. 
The use of TLC as a means of tracking elution of the material became a difficult task.  
Visualization of TLC plates was not a viable option as none of the reaction components were 
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observed using a UV lamp, which is due to the lack of aromatic or -conjugated functional 
groups.  However, after testing several visualization methods, the iodine method was determined 
to be useful for the co-monomer.  For the reactions involving the catalyst synthesized in-house, 
two spots were visible at Rf 0.07 and Rf 0.44 in a 10% ethyl acetate‒hexanes mobile phase.  After 
purification of the material using column chromatography, the two spots were separated.  After 
concentration under reduced pressure and removal of residual solvents under vacuum, the spot at 
Rf 0.07 was identified as CYGEP using 
1
H NMR spectroscopy, while the band at Rf 0.44 was 
identified as a mixture of unreacted vinyl epoxide plus other potential side products.  While 
separation of the two bands was possible, bleeding of the two bands was observed regardless of 
the size and solvent gradient used, which resulted in a decrease in the obtainable yields.  
When the commercial Lamoreaux’s catalyst was used, the same two bands at Rf 0.07 and 
0.44, as well as two additional bands were present.  These bands at Rf 0.21 and 0.28 had not been 
previously detected in the synthesis of CYGEP.  Elution of the crude material allowed for the 
isolation of fractions of the unreacted vinyl epoxide/unidentified products and CYGEP bands 
which were previously isolated, but similar bleeding made isolation of the middle two bands 
unobtainable.  Collection of a mixture of the bands at Rf 0.21 and 0.28 with a small amount of 
CYGEP present was obtained.  The 
1
H NMR spectrum was very similar to that of CYGEP, but 
with the peak at 4.6 ppm in higher proportion than previously seen. 
The purification of CYGEP was achieved through the use of column chromatography 
using a 10% ethyl acetate‒hexanes mobile phase.  While effective, this procedure did present 
complications in terms of the bleeding of bands together regardless of column size and length.  
In the use of both catalysts, isolation of both major bands was accomplished, but complete 
isolation of the two unique bands in the Gelest reactions was unsuccessful.    
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CYGEP Byproducts 
Similar to PHEPSI, the synthesis of CYGEP produced more than one product.  In our 
investigation, two versions of Lamoreaux’s catalyst were utilized.  Both provided products at Rf 
0.07 and 0.44 when run on TLC (10% ethyl acetate‒hexanes mobile phase).  In addition to the 
two products, the Gelest catalyst also included products at Rf 0.21 and 0.28.  After purification, 
the TLC spot at 0.07 was determined to be CYGEP through 
1
H and 
13
C NMR spectroscopy.  The 
product with Rf 0.44 was able to be isolated, but the 
1
H NMR spectra collected varied from batch 
to batch.  Since the reaction was run in an excess of the vinyl epoxide, unreacted starting 
materials were identified to be in the band.  However, as in the case of PHEPSI, the band often 
contained a multiplet between 5.0-5.3 ppm in the 
1
H NMR spectrum.  Other discernible 
irregularities included the presence of several singlets between 2.4-2.8 ppm.  Due to the variance 
of the peaks from reaction to reaction, identification of the additional products in the band has 
not been completed.  The presence of peaks in the vinylic region of the 
1
H NMR spectrum raises 
the possibility of the presence of a minor amount of the dehydrogenated product.  
Mechanistically, this result would not be expected, as platinum-based hydrosilylations are 
generally known to proceed through the Chalk-Harrod pathway.  However, recent reports of 
some platinum or palladium catalysts producing the dehydrogenated vinylsilane introduce the 
possibility of this byproduct.
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Bleeding of the bands together prevented the isolation of the products at Rf 0.21 and 0.28.  
Instead, the bands were collected containing minimal amounts of CYGEP.  
1
H NMR spectra of 
these samples showed an increased intensity of the peaks at 0.1 and 4.6 ppm, while 
13
C spectra 
showed differences at -1.2 and 0.9 ppm.  Taking these results in combination with the presence 
of a band at 2100 cm
-1
 in the IR spectrum, it is believed that complete conversion of all four Si-H 
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bonds did not occur.  The resulting structures are believed to be a combination of a di-
functionalized monomer or the tri-functionalized monomer seen in Figure 24.  
CYGEP Optimization Recap 
 The synthesis of the second silorane monomer, CYGEP, was achieved after an 
investigation which spanned differing procedures and the use of two versions of Lamoreaux’s 
catalyst.  The hydrosilylation of 4-vinylcyclohexene-1,2-epoxide with 2,4,6,8-
tetramethylcyclotetrasiloxane and a synthesized version of Lamoreaux’s catalyst was achieved in 
moderate yields (63%) utilizing an adapted procedure of Aoki.  Under similar conditions, the 
utilization of a platinum octanal/octanol complex produced the silorane, albeit in decreased 
yields (46%).  Both reactions formed a minor amount of unidentified byproducts.  It is 
hypothesized that those reactions using the Gelest complex exhibited a dependence between the 
concentration of the catalyst and substitution of all four Si-H bands.  Lower concentrations of 
catalyst resulted in an increasing ratio of unreacted Si-H moieties consequently producing the 
mono-, di-, and trisubstituted monomers along with the desired tetrafunctional CYGEP.  For 
synthetic purposes, optimal conditions for the production of CYGEP require the addition of 0.5 
mL of a 0.50% in-house prepared Lamoreaux’s catalyst solution diluted in toluene to be added to 
a solution of the starting reagents previously heated to 70 °C for 30 min.  However, for purposes 
of using CYGEP as a co-monomer in a chemically cured biomaterial, the addition of 1.0 mL of a 
0.79% solution of Lamoreaux’s catalyst (Gelest) in toluene is the optimal catalyst condition.      
Monomer Storage and Stability 
 Once isolated, both monomers were stored until a sufficient quantity of each was 
produced to make a batch of SilMix (typically between 40-60 g of each monomer).  Prior to 
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mixing, both monomers were stored inside amber bottles under argon at 8-10 ºC.  Unfortunately, 
the length of storage time varied depending on the efficiency at which the monomers were 
produced.  During prolonged storage, new peaks were observed in the NMR spectra of PHEPSI.  
After two weeks, noticeable peaks formed in the vinylic region for both 
1
H (Figure 25, 4.5-6.0 
ppm) and 
13
C NMR (Figure 26, 110-150 ppm), which were not present in the spectrum of the 
initially purified sample. 
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Figure 25: 
1
H NMR spectrum of PHEPSI decomposition. 
  
5
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Figure 26: 
13
C NMR spectrum of PHEPSI decomposition.
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Further analysis indicated these peaks were associated with slight decomposition/polymerization 
of PHEPSI and not through the addition of an outside contaminant.  For use as a co-monomer of 
a biomaterial, the storage stability of PHEPSI needed to be improved.  A comparative 
investigation of CYGEP revealed no such decomposition after a period of six months (Table 12).  
With the observed stability of CYGEP and plans for its use as a co-monomer system, we 
investigated the effect on its stability when combined to form SilMix.  After two years, no 
degradation was observed as determined by 
1
H NMR.  When combined, the higher viscosity 
silorane CYGEP provides a stabilizing effect on PHEPSI. 
 
 
    
Table 12: Stability of SilMix components. 
System Stability 
PHEPSI 1 month 
CYGEP >6 months 
SilMix >2 years 
 
 
 
Once we became aware of the decomposition issue, special attention was paid to the storage and 
handling procedures which increased the stability of PHEPSI to approximately one month (Table 
12).  Once purified, monomers were stored in oven-dried amber glass vials or sterilized plastic 
cups in the refrigerator.  A protocol was established for the mixing of monomers no more than 
one month post isolation of PHEPSI in order to prevent the possibility of monomer 
decomposition.   
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Quality Control Exploration 
 The use of a biomaterial as a novel bone cement from bench top to bedside requires the 
need to problem-solve any potential complications which could detract from the use of this 
material.  During the development of the dually cured bone cement, a freshly mixed batch of 
SilMix failed to polymerize upon addition of Lamoreaux’s catalyst.  Several additional samples 
were evaluated from the same batch, all resulting in failure of the 1-lb Gilmore needle test for 
polymerization.  In an effort to discover the cause for the failure, an investigation of quality 
control of the resin production was commenced (Tables 13 and 14). 
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Table 13: Quality control steps for CYGEP. 
Batch Location 
2,4,6,8-
TMCTS Vinyl Epoxide Lamoreaux's Catalyst Hexanes Silica Gel Polym 
CYGEP 48 FH 524 Gelest, >95% Gelest, >97% In house (bm207) Aluminum can Lot #: 020427 No 
CYGEP 49 FH 524 Alfa, 99% Gelest, >97% In house (bm207) Aluminum can Lot #: 020427 No 
CYGEP 50 FH 524 Alfa, 99% Gelest, >97% In house (5bm015) Aluminum can Lot #: 020427 No 
CYGEP 51 FH 524 Alfa, 99% Gelest, >97% In house (5bm015) Aluminum can Lot #: 011014I No 
CYGEP 52 FH 528 Alfa, 99% Gelest, >97% In house (5bm015) Aluminum can Lot #: 020427 No 
CYGEP 53 FH 528 Alfa, 99% Gelest, >97% In house (5bm015) Aluminum can Lot #: 051113J No 
CYGEP 55 FH 528 Alfa, 99% Gelest, >97% In house (5bm015) Aluminum can Lot #: 051113J No 
CYGEP 57 FH 528 Alfa, 99% Gelest, >97% In house (5bm015) Glass bottle Lot #: 051113J No 
CYGEP 58 FH 528 Alfa, 99% Gelest, >97% Gelest, <10% complex Glass bottle Lot #: 051113J Yes 
CYGEP 59 FH 528 Alfa, 99% Aldrich, 98% In house (5bm015) Glass bottle Lot #: 051113J Yes 
CYGEP 60 FH 528 Alfa, 99% Aldrich, 98% Gelest, <10% complex Glass bottle Lot #: 051113J Yes 
CYGEP 61 FH 528 Alfa, 99% Aldrich, 98% Gelest, <10% complex Glass bottle Lot #: 051113J Yes 
Polym. = passing of the 1-lb Gilmore needle test at 1 hr. 
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Table 14: Quality control steps for PHEPSI. 
Batch Location MPS Vinyl Epoxide 
Wilkinson's 
Catalyst Hexanes Silica Gel Polym 
PHEPSI 79 FH 524 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 020427L No 
PHEPSI 80 FH 524 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 020427L No 
PHEPSI 81 FH 524 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 020427L No 
PHEPSI 82 FH 524 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 020427L No 
PHEPSI 83 FH 524 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 011014I No 
PHEPSI 84 FH 528 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 020427L No 
PHEPSI 85 FH 528 Gelest, >95% Gelest, >97% Alfa, 97% Aluminum can Lot #: 051113J No 
PHEPSI 87 FH 528 Gelest, >95% Gelest, >97% Alfa, 97% Glass bottle Lot #: 051113J No 
PHEPSI 88 FH 528 Gelest, >95% Gelest, >97% Alfa, 97% Glass bottle Lot #: 051113J No 
PHEPSI 89 FH 528 Gelest, >95% Aldrich, 98% Strem, 99% Glass bottle Lot #: 051113J Yes 
PHEPSI 90 FH 528 Gelest, >95% Aldrich, 98% Strem, 99% Glass bottle Lot #: 051113J Yes 
PHEPSI 91 FH 528 Gelest, >95% Aldrich, 98% Strem, 99% Glass bottle Lot #: 051113J Yes 
PHEPSI 92 FH 528 Gelest, >95% Aldrich, 98% Strem, 99% Glass bottle Lot #: 051113J Yes 
PHEPSI 93 FH 528 Gelest, >95% Aldrich, 98% Strem, 99% Glass bottle Lot #: 051113J Yes 
Polym. = passing of the 1-lb Gilmore needle test at 1 hr. 
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Shelf Life 
 This unreactivity occurred between differing batches of SilMix.  Therefore, the shelf 
life of the failed materials was examined.  Once a batch was purified, an 
1
H NMR spectrum 
was collected.  The batches were combined in an amber jar and kept in the refrigerator at 6 
ºC until a sufficient amount of both monomers was available for mixing.  Storage of the 
individual monomers was typically no more than three weeks after purification.  In the case 
of SilMix 41, the first batch of each monomer placed in the stock had been purified more 
than eight weeks prior to mixing.  From this information, it was determined to investigate 
whether the shelf life of the individual monomers was the overriding factor in the failure of 
the system to polymerize.   
 To test this, PHEPSI 79 and CYGEP 48 were synthesized using the same reagents 
that were used to prepare the materials for SilMix 41.  Once the pure monomers were 
isolated, they were mixed within hours of the collected NMR spectrum.  The resulting resin 
again failed to harden during the expected time period as determined by the GNT.  PHEPSI 
80 was also purified and combined with CYGEP 48 yielding similar results.  Further 
variables were then explored as the cause of the problem. 
Reagents 
 The next variable examined was the starting reagents involved in the synthesis of the 
monomers.  The possibility that an unknown contaminant may have affected the monomers 
resulted in the acquisition of new starting materials.  For the synthesis of CYGEP, the 
original procedure utilized 2,4,6,8-tetramethylcyclotetrasiloxane purchased from Alfa Aesar 
(99% purity), but in the previous year the suppliers were switched to Gelest (>95% purity) 
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for budgetary reasons.  During the change, no change in yields or reaction conditions had 
been observed.  It was decided to return to the materials from Alfa in order to use the highest 
purity reagents available, and were ones known not to have any prior issues for our system.   
1
H NMR spectra were taken of the newly acquired starting materials and compared with the 
previously used starting materials.  There was no decomposition or added impurities in any 
of the samples of the starting materials.  PHEPSI 81 and CYGEP 49 were then prepared 
using the new materials. Again, the sample failed the Gilmore needle test after 1 h.  With 
similar results to the previous trials, alternative variables were examined.   
Platinum Catalyst Poisons 
While the use of a platinum catalyst in the synthesis and polymerization of a 
biomaterial has shown tremendous potential, however, loss of reactivity of platinum catalysts 
due to poisoning of the system by outside factors has been reported in the literature.
83
  
Depending on the type and formulation of the reaction, the extent of the effect may range 
from slightly slowed reaction time to complete reaction inhibition.  Platinum catalysts have a 
long list of potential poisons, including sulfur compounds, amines, phosphines, silver salts, 
and tin salts, to name a few.  The presence of these types of compounds in the working 
environment could potentially lead to loss of polymerization of the biomaterial.  Those 
compounds in the laboratory, which may contain any of these poisons, were moved to an 
adjoining room in an effort to eliminate potential inhibition.   
Cleaning of Glassware and Laboratory 
 With the synthesis of the monomers taking place in a multi-project laboratory, the 
laboratory was cleaned to remove any potential impurities that may have been lingering and 
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undetected.  The continued production of additional monomers, which failed to polymerize 
called for further action.  The synthesis of SilMix was then moved to an unoccupied 
laboratory in which no other chemical syntheses were being performed at the time.  Prior to 
this transfer, all supplies and equipment were either purchased new or thoroughly cleaned.  A 
protocol was developed to clean all glassware using NOCHROMIX.    
 The laboratory transfer began by initially taking a step backwards.  The first few 
batches produced (PHEPSI 84 and CYGEP 52) introduced additional complications.  In the 
1
H NMR spectrum, unanticipated peaks were found at 4.26 (quartet) and 8.11 (singlet).  With 
a new glassware-cleaning protocol, newly used equipment, and a new environment, several 
variables were incorporated.  Detection of the unique peaks was not observed until after the 
crude monomer was run through a column and concentrated under reduced pressure.  The 
first step taken was to collect NMR spectra of all the solvents (hexanes, ethyl acetate, 
acetone, and toluene) used in purification of the monomers.  All spectra were absent of the 
unique peaks.  With the solvents ruled out, focus was shifted to the equipment.  A different 
rotary evaporator due to the location change was examined.  The apparatus was 
disassembled, thoroughly cleaned, and reassembled numerous times.  After each cleaning, a 
sample was concentrated and an 
1
H NMR spectrum collected.     Each sample produced a 
spectrum in which the unique peaks were still present in varying intensities.  With no 
correlation between the rotary evaporator and the intensity of the peaks, alternative sources 
of these peaks were investigated.   
 Conscious of the fact that the monomers are higher viscosity liquids, the issue of 
solvent purity was re-evaluated.  An experiment was conducted in which 10-mL samples of 
hexanes, ethyl acetate, acetone, and a 10% ethyl acetate‒hexanes solution were placed into 
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vials and concentrated to dryness.  An 
1
H NMR spectrum was collected, and the unique 
signals due to the contaminant were observed in both the hexanes and 10% ethyl acetate‒
hexanes solution.  A fresh container of hexanes was opened, and the above experiments 
rerun.  The disappearance of those signals led to the determination that an impurity was 
present at minimal levels in the previous supply of hexanes.  This conclusion led to the 
decision to purchase solvents in glass bottles rather than large quantities in aluminum cans to 
prevent possible contamination from the aluminum containers.   
Change in Wilkinson’s Catalyst and Reaction Procedure 
 Returning to the issue of polymerization, GNT tests were run using the individual 
monomers.  Experiments of the individual monomers revealed substantial information 
because CYGEP samples would pass the polymerization tests while PHEPSI samples would 
not.  Therefore, the synthesis of PHEPSI became the primary focus of this investigation.  
With no recent change in the synthetic procedure, it left Wilkinson’s catalyst as the potential 
problem.  A comparison of the certificates of analysis in the varying lots revealed a 
difference of trace metals present.  Due to the variability of trace metals from lot to lot for 
Wilkinson’s catalyst supplied by Alfa (97%), an alternative supplier was sought.  It was 
found that Wilkinson’s catalyst could be purchased through Strem Chemicals at 99% purity. 
 Meanwhile, a closer look at the mechanism of hydrosilylation reactions and previous 
examples from the literature indicated that the order of addition of reagents may have an 
effect on the product distribution.  Mechanistically, the addition of the silane to the catalyst 
allows for the oxidative addition in Chalk-Harrod pathway to begin prior to the addition of 
the alkene.  Thus, the addition of the alkene to the metal intermediate may drive the pathway 
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directly to reductive elimination and minimize the quantity of material that passes through 
the -hydrogen abstraction route.  Therefore, the procedure for the synthesis of PHEPSI was 
altered such that methylphenylsilane was added to the catalyst stirring in toluene and the 
vinyl epoxide was added afterwards, a minimum of 10 min later to allow for the metal-silyl 
intermediate to begin formation. 
  After the changes in catalyst and modification of the procedure were implemented, 
the polymerization tests were again performed with much improved results (Table 15). 
 
 
 
Table 15: Modifications for the synthesis of PHEPSI. 
Procedure Wilkinson’s Catalyst Solvents Reagent Addition 
Original Alfa (97%) 
Large quantity 
(aluminum cans) 
No specific order 
Revised Strem (99%) 
Smaller quantity 
(glass bottles) 
MPS added to 
catalyst followed 
by vinyl epoxide 
(after at least 10 
min) 
 
 
 
A positive test for polymerization of the new co-monomers was indicated by passing of the 
1-lb GNT at 1 h.   From these results, it was concluded that the major contributors to 
polymerization inhibition in this case were the variability in trace metals present from the 
lower-purity Wilkinson’s catalyst and the order of reagent addition in the synthetic procedure 
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for PHEPSI.  Therefore, the former was accomplished by the purchase of a higher-grade 
(99% purity) Wilkinson’s catalyst, while the latter was a result of procedural changes.  
Additionally, a protocol was established for the purchase of solvents in glass bottles as 
compared to aluminum cans, as well as transfer of solvents from larger containers, which 
may introduce a contaminant from the linings.   
CYGEP Polymerization Complications 
 Shortly after overcoming the loss of polymerization due to the obstacles surrounding 
the synthesis of PHEPSI, complications arose with CYGEP.  Due to the loss in 
polymerization previously, subsequent batches of both monomers were tested individually to 
check for changes in reaction time.  Upon testing this procedure, several batches of CYGEP 
failed to pass the 1-lb GNT at 1 h.  Examination of several batches of CYGEP indicated a 
link between failure of the test and the percent and type of catalyst used (Table 16).   
 
 
 
  
70 
 
Table 16: Comparison of catalyst type and concentration in the polymerization of CYGEP.  
Batch Catalyst Cat % IR Si-H  
NMR ~4.6 
ppm Polym. 
CYGEP 58 Gelest 0.65 No Yes Pass 
CYGEP 59 5bm015 0.55 No Yes FAIL 
CYGEP 60 Gelest 0.66 Yes Yes Pass 
CYGEP 61 Gelest 0.64 Yes Yes Pass 
CYGEP 62 Gelest 0.70 Yes Yes Pass 
CYGEP 63 Gelest 0.50 Yes Yes Pass 
CYGEP 64 Gelest 0.72 Yes Yes Pass 
CYGEP 65 Gelest 1.5 Yes Yes Pass 
CYGEP 66 Gelest 1.75 No No FAIL 
CYGEP 67 5bm042 0.50 No Yes FAIL 
CYGEP 68 Gelest 1.75 No No FAIL 
CYGEP 69 Gelest 1.62 Yes Yes Pass 
CYGEP 70 Gelest 3.14 Yes Yes FAIL 
CYGEP 71 Gelest 1.91 Yes Yes Pass 
CYGEP 72 Gelest 3.14 Yes Yes FAIL 
CYGEP 73 5bm078 0.59 Yes No FAIL 
CYGEP 75 Gelest 0.79 Yes Yes Pass 
CYGEP 76 Gelest 0.79 Yes Yes Pass 
CYGEP 77 Gelest 0.79 Yes Yes Pass 
CYGEP 78 Gelest 0.79 Yes Yes Pass 
CYGEP 79 Gelest 0.79 Yes Yes Pass 
CYGEP 80 Gelest 0.79 Yes Yes Pass 
Polym: Pass = passage of the 1-lb Gilmore needle test at 1 h. 
 
 
 
The results indicate an interesting correlation between batches of CYGEP made using the in-
house developed catalyst and failure of polymerization.  Those batches which were 
synthesized using the in-house catalyst failed to pass the polymerization test after 1 h.  The 
type of catalyst used is not the only predictor for test failure, though.   With one exception, 
trials which used a weight percent over 1.75% of catalyst:toluene failed to pass the 1-lb test 
at 1 h.  Upon closer examination, it was determined that use of a 0.79% solution of the 
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octanal/octanol complex provided the best conditions at which polymerization was 
consistently observed.  Examination of the spectra from these batches presented interesting 
clues to the complications.  The batches which showed no indication of the signal at 4.6 ppm 
in the 
1
H NMR spectrum failed to polymerize.  Additionally, those batches with the signal at 
4.6 ppm visible, but at a low ratio failed to pass the test as well.  However, batches which 
indicated a strong peak at 4.6 ppm followed in line with previous work and passed the 1-lb 
test at 1 h.  Using the preceding data, the procedure for ensuing reactions of CYGEP was 
determined to require the use of the platinum octanal/octanol complex at 0.79% by weight 
for reproducible polymerization results. 
Quality Control Recap 
 From the conception of an idea to a commercial entity, several factors play into the 
time frame in which the development proceeds.  One such factor of high importance for any 
innovation is the generation of a set of quality control and analysis guidelines.  These 
guidelines enable the product to be commercialized safely and reproducibly.  In the 
development of a biomaterial with the specific target as a bone cement, numerous synthetic 
barriers were encountered and overcome.  The successful completion of synthetic procedures 
for the silorane monomers PHEPSI and CYGEP marked the beginning of the journey to a 
viable biomaterial.  Careful examination of the variables indicated that the procedures of both 
monomers required modifications.  In the synthesis of PHEPSI, due to the variability of trace 
metals a higher quality grade of Wilkinson’s catalyst (99% purity) was required.  
Additionally, the order of addition of the reagents was determined to potentially reduce the 
quantity and type of byproducts from the reaction.  For CYGEP, the use of the Gelest 
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Lamoreaux’s catalyst at 0.79% provided the appropriate conditions for a material to 
polymerize as needed.   
Conclusion 
  Adapted procedures for the synthesis of PHEPSI and CYGEP and quality control 
guidelines were developed and optimized for the production of silorane monomers for use as 
a biomaterial.  The optimal procedure for PHEPSI entailed the utilization of a crystalline 
powder version of Wilkinson’s catalyst (>99% purity) and heating the reaction mixture to 95-
100 °C for 18-24 h.  The addition of 4-vinylcyclohexene-1,2-epoxide as the final component 
of the starting materials reduced the production of byproducts.  Development of a 
reproducible synthetic procedure for CYGEP was accomplished only after the inclusion of 
acetonitirile in the reaction mixture.  Attempts to synthesize the monomer without 
acetonitrile led to polymerization upon addition of Lamoreaux’s catalyst.  The use of two 
different catalysts produced differing results.  Lamoreaux’s catalyst as supplied by Gelest 
(1.0 mL of a 0.79% solution) produced CYGEP with an additional signal at 4.6 ppm in the 
1
H NMR spectrum while the signal was absent in reactions utilizing the in-house LMC (0.5 
mL of a 0.5% solution).  Optimal reaction conditions for CYGEP, regardless of the 
Lamoreaux’s catalyst utilized, required heating to 70 ºC for 30 min.  
 A quality control analysis for our bone cement formulations was investigated.  A loss 
of polymerization occurred in formulations where PHEPSI had been synthesized using a 
lower grade of Wilkinson’s catalyst (97%).  The variation of the trace metals was found to 
contribute to the loss of polymerization and thus a higher grade catalyst (>99%) was 
designated for use in this preparation.  PHEPSI was found to begin to decompose 
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approximately one month after purification.  However, it was discovered that decomposition 
can be prevented by the mixing of PHEPSI with CYGEP in a 1:1 ratio by weight.  Thus, for 
monomers designed for the biomaterial, use of the Gelest Lamoreaux’s catalyst was found to 
be optimal.  
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Experimental section 
General procedures.  Proton NMR spectra were recorded on a Varian AC 400 MHz 
spectrometer.  Carbon NMR spectra were recorded on a Varian AC 400 spectrometer 
operating at 100 MHz.  All commercial chemicals and solvents were used as supplied unless 
otherwise stated.  Anhydrous toluene (>99.8%), 4-vinylcyclohexene-1,2-epoxide (98%), and 
octanol (>99%) were purchased from Aldrich.  2,4,6,8-Tetramethylcyclotetrasiloxane (99%) 
was purchased from Alfa Aesar.  Methylphenylsilane (>95%) and platinum octanal/octanol 
complex (2.0-2.5% Pt in octanol) were purchased from Gelest.  The chloroplatinic acid 
hexahydrate (99.9% Pt) and Wilkinson’s catalyst (>99%) were purchased from Strem 
Chemicals.   
bis[2-(3{7-oxabicyclo[4.1.0]heptyl})ethyl]methylphenyl silane (PHEPSI, 5).  PHEPSI was 
synthesized from an adapted procedure by Crivello.
41
  Wilkinson’s catalyst (40 mg) and 
methylphenylsilane (11.0 mL, 9.79 g, 80.1 mmol) were added to toluene (80 mL) and stirred 
for 10 min under argon.  4-Vinyl-1-cyclohexene-1,2-epoxide (25.2 mL, 24.0 g, 193.0 mmol) 
was added, and the solution was heated to 95 °C for 18-24 h.  The reaction was monitored for 
the disappearance of the Si-H peak from methylphenylsilane at 2160 cm
-1
 by IR 
spectroscopy.  The solvent was removed via vacuum.  The resulting dark orange liquid was 
purified using column chromatography (silica gel; solvent: solvent gradient hexanes, 2% 
ethyl acetate‒hexanes, 4% ethyl acetate‒hexanes, 6% ethyl acetate‒hexanes, 8% ethyl 
acetate‒hexanes, and 10% ethyl acetate–hexanes).  Residual ethyl acetate and hexanes were 
removed via vacuum to obtain PHEPSI (19.8 g, 53.4 mmol, 66.7%) as a colorless viscous 
liquid.  
1
H NMR (CDCl3, 399.8 MHz)  0.22  (s, 3H), 0.67-0.73 (m, 4H), 0.79‒2.19 (m, 
18H), 3.10‒3.16 (m, 4H), 7.34‒7.35 (m, 3H), 7.44‒7.46 (m 2H) ppm; 13C NMR (CDCl3, 100 
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MHz)   -5.4, 10.6, 10.8, 23.6, 23.9, 25.3, 26.7, 30.1, 30.3, 30.6, 31.5, 32.5, 35.5, 51.9, 52.0, 
52.7, 53.3, 127.7, 128.8, 133.7, 138.2 ppm.  
2,4,6,8-tetrakis(2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl)-2,4,6,8-tetramethyl-
1,3,5,7,2,4,6,8-tetraoxatetrasilocane (CYGEP, 6).   CYGEP was synthesized from an 
adapted procedure by Aoki.
82
  2,4,6,8-Tetramethylcyclotetrasiloxane (12.1 mL, 12.0 g, 49.9 
mmol), 4-vinyl-1-cyclohexene-1,2-epoxide (31.3 mL, 29.8 g, 240.0 mmol), acetonitrile ( 0.5 
mL, 0.4 g, 10 mmol), and toluene (21 mL) were heated at 70 °C for 30 min.   Lamoreaux 
catalyst (0.5 mL of 0.5% solution in toluene, prepared in-house) was slowly added.  Upon 
addition, the temperature increased to ~130 °C for 10 min before slowly cooling to rt while 
stirring.  The reaction was monitored for the disappearance of the Si-H peak from 2,4,6,8-
tetramethylcyclotetrasiloxane at 2100 cm
-1
 by IR spectroscopy.  The solvent was removed 
via vacuum.  The clear liquid was purified using column chromatography (silica gel; solvent: 
solvent gradient hexanes, 2% ethyl acetate‒hexanes, 4% ethyl acetate‒hexanes, 6% ethyl 
acetate‒hexanes, 8% ethyl acetate‒hexanes, and 10% ethyl acetate–hexanes).  Residual ethyl 
acetate and hexanes were removed via vacuum to obtain pure CYGEP (23.1 g, 31.3 mmol, 
62.8%) as a colorless viscous liquid.  
1
H NMR (CDCl3, 399.8 MHz)   0.03 (s, 12H), 0.46 (t,  
J = 8 Hz, 8H), 0.81‒2.19 (m, 36H), 3.14‒3.17 (m, 8H) ppm; 13C NMR (CDCl3, 100 MHz)  -
0.8, 13.9, 14.0, 14.1, 23.6, 24.0, 24.1, 25.3, 26.8, 29.3, 29.8, 30.4, 31.5, 31.6, 32.0, 32.1, 35.1, 
35.2, 51.9, 52.0, 52.7, 53.2 ppm  
Lamoreaux’s catalyst (56) was synthesized from an adapted procedure by Lamoreaux.74  
Chloroplatinic acid hexahydrate (2.89 g, 7.05 mmol) and octanol (6 mL) were heated to 55 
°C for 42 h under vacuum.  The black solution was vacuum filtered and washed with hexanes 
(15 mL).  The filtrate was placed under vacuum for 8 h to remove solvents.  The remaining 
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black liquid (~2 mL) was placed in the refrigerator under argon and used without any further 
purification. 
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CHAPTER 2 
SYNTHESIS AND ANALYSIS OF EXTENDED TWISTED MOLECULAR RIBBONS 
Introduction 
Over the last few decades, there has been an increased interest in the synthesis and 
applications of polycyclic aromatic hydrocarbons (PAH), especially in the area of acenes.
84-88
 
 
Acenes, linearly fused benzenes, are a series of compounds that have been used for a wide 
range of purposes, including moth repellents, artificial dyes, and more recently in the 
materials field due to their semiconducting potential which arises from the extensive 
conjugated system with lower energy bandgaps.86, 89-91  As a result, acenes have been 
targeted and used in technological applications, such as organic light-emitting diodes 
(OLEDs), organic field-effect transistors (OFET’s), organic photovoltaics, and even solar 
cells.
87, 92-96
  This potential has increased interest in the field and thus allowed for the 
development and study of this class of compounds to be pushed to remarkable lengths. 
The shortest and most abundant acenes are those of benzene (65), naphthalene (66), and 
anthracene (67) with one-, two-, and three-fused benzene units, respectively (Figure 27).
90, 97
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Figure 27: Structure of acenes from benzene (65) through heptacene (71). 
 
 
 
The intermediate acenes, which include tetracene (4 units, 68) and pentacene (5 units, 69), 
have garnered a great deal of attention over the last few decades in part due to their high 
charge-carrier mobilities and decreasing HOMO-LUMO gaps.
84
  More recently, the 
attempted syntheses of higher-order acenes, hexacene (6 units, 70) and heptacene (7 units, 
71), have been of investigated for this same reason, but have faced several challenges along 
the way.   
Synthetic Challenges 
 The extension of the higher-order acenes produces compounds with increasingly 
interesting electronic properties, including higher charge-carrier mobilities and smaller band 
gaps.  However, this increase comes at the cost of solubility and stability.
89, 92, 98
  An added 
challenge comes from the limited amount of publications for the synthesis of higher-order 
acenes, especially with the numerous accounts of withdrawn or retracted reports.
99-101
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Regardless, several procedures have been developed for the formation of the higher-order 
molecules.  Pentacene (69) has been synthesized through the aldol condensation of 
phthalaldehyde (72) and 1,4-cyclohexanedione (73) to give quinone 74 which was then 
reduced to the acene (Figure 28).
102
   
 
 
 
 
Figure 28: Synthesis of pentacene 69. 
 
 
 
Unfortunately, even in dilute solutions of 1,2-dichlorobenzene, 69 will begin to oxidize to 
quinone 74 and/or dimerize to the “butterfly dimer” (75, Figure 29) within five minutes 
unless it is carefully isolated from air and light.
71, 91, 103
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Figure 29: Butterfly pentacene dimer. 
 
 
 
Successful syntheses of both hexacene (70) and heptacene (71) have been reported in the 
literature, but the extremely low solubility and stability of these molecules have made 
advanced studies on these compounds very difficult.
84, 91
  Recently, Watanabe et al. reported 
a solid-state procedure for the synthesis of hexacene (70), which when prepared and stored in 
the dark was stable for more than one month (Figure 30).
104
  
 
 
 
 
Figure 30: Formation of hexacene (70) from the monoketone precursor 76. 
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However though, similar to pentacene, both 70 and 71 are susceptible to decomposition 
and/or dimerization.    
 The susceptibility of acenes to decompose or dimerize is caused by a nonequivalency 
of bonds in the aromatic system due to partial bond fixation.  In the case of naphthalene, the 
C1‒C2 bond is more apt to be attacked because of the higher double bond character observed 
in resonance forms. 
 
 
   
 
Figure 31: Higher reactivity sites for naphthalene (66), anthracene (67), and pentacene (69) 
and the resonance structures of anthracene (67a-67d).   
 
 
 
In the case of anthracene, the 9,10-positions are the reactive hotspot, especially for 
Diels-Alder reactions, such as the addition of maleic anhydride.
105
  This is due to the bond 
order from the possible resonance structures.  In addition to the double bond character, 
formation of two isolated benzene rings factors into the increased reactivity at the 9,10-
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positions of anthracene.
106, 107
  Finally, following the trend to pentacene, reactions such as 
decomposition to the quinone or dimerization at the 6,13-positions would divide the skeleton 
into two separate naphthalene systems within the molecule.
108, 109
  The understanding of this 
process has allowed for the development of strategies to reduce reactivity at these positions 
and thus increase the versatility of the compounds.     
The Effect of Substitution on Acenes 
 Due to the high reactivity and low solubility of acenes, most notably pentacenes, 
research has been directed towards syntheses and studies entailing the effects resulting from 
the addition of functional groups to the acene skeleton.
87, 110, 111
  One such strategy has been 
the addition of bulky substituents through the reduction of a quinone.  The use of lithium 
reagents for the reduction of a carbonyl group to an alcohol have been used previously in the 
synthesis of substituted acenes (Figure 32) .
85, 91, 112, 113
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Figure 32: Reduction of acene quinones using organolithium adducts (two equivalents). 
 
 
 
Reduction of the quinone with an organolithium reagent results in a diol which can then be 
aromatized to the acene by a subsequent reduction using one of several reducing agents (i.e., 
HI, NaH2PO4, or SnCl2).  One of the first reported functionalizations of both anthracene and 
pentacene was the addition of phenyl and phenylethynyl groups to the acene skeleton at the 
reactive positions of the acenes (C9‒C10 and C6‒C13, respectively) by Maulding and 
Roberts.
114
  Substitution was accomplished by reduction of the respective quinone with the 
corresponding organolithium adduct, followed by aromatization with tin chloride to give the 
derivatives of 79 (Figure 33).
114
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Figure 33: Structures of substituted anthracene (R = H, 80a; -C≡CC6H5, 80b; -C6H5, 80c; and 
–CH=CHC6H5, 80d) and pentacene (R = H, 81a and -C≡CC6H5, 81b). 
 
 
 
The resulting molecules had an increased fluorescence efficiency and large red shifts to 
longer wavelengths of emission and absorption spectra in comparison to the unsubstituted 
acenes (Table 17).
111
  
 
 
 
Table 17: UV-Vis absorption and fluorescence of substituted and unsubstituted acenes.
111
 
Compound Absorption (nm) Fluorescence (nm) 
Anthrancene (67) 382 388 
Phenylethynyl anthracene (80b) 455 486 
Pentacene (69) 576 578 
Phenylethynyl pentacene (81b) 655 680 
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As a result of this successful approach, numerous additional 6,13-pentacene derivatives have 
been synthesized utilizing organolithium reagents.
85, 91
  In general, the 6,13-disubstituted 
pentacenes have increased stability and solubility as compared to the unsubstituted molecule.  
An investigation by Ono et al (Figure 32) found pentacenes 79a-c to be soluble in common 
organic solvents while pentacene is not.
113
  Additionally, pentacene 79c was stable in 
solution for up to 2 h.   However, functionalization of the acene skeleton has also been 
expanded to sites other than the most reactive positions in an effort to increase stability.
89, 115-
117
  
 
 
 
 
Figure 34: Additional substituted pentacenes 82-84 at other positions. 
 
 
 
Interestingly, incremental substitution to the acene skeleton introduces a deformation to the 
structure.
118
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Acene Twist 
 The idea that acenes are flat molecules is a common misconception.  In fact, the 
energy required to deform many polycyclic aromatic compounds from planarity is quite 
modest (e.g., only 3.2 kcal/mol is needed to twist naphthalene by 20º).
118
  The simple acenes 
have a small bend to their structure while more substituted compounds have a twist and will 
bend out of plane due to sterics.  This “twisting” along the central unit is calculated from the 
torsion of angles ABCD (Figure 35) and typically becomes more prominent in molecules that 
contain a higher degree of substitution (steric crowding) or benzannulated molecules.   
 
 
   
 
Figure 35: Torsion angles used in the determination of molecule twist, ABCD or BADC. 
 
 
 
The extent of twist as a result of substitution may most simply be described by the sterics of 
the substituents.  In the simpler cases, persubstitution of naphthalene with bromine, chlorine, 
and methyl groups highlights the effect bulkiness has on degree of twist (Figure 36).
119, 120
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Figure 36: Structures of persubstituted twisted naphthalenes 85a-d and anthracene 86. 
 
 
 
Octabromonaphthalene (85a) exhibits a 31º end-to-end twist while the octachloro- (85b) and 
octamethylnaphthalene (85c) are slightly less twisted at 24º and 26º, respectively.  When 
overcrowding is caused by phenyls as in compound 85d, the naphthalene core remains 
essentially untwisted, while the phenylated anthracene 86 becomes highly twisted at 63º due 
to the severe peri interactions.
118
  Peri interactions are the steric effects rising from bumping 
of atoms along the acene framework.
121
  In naphthalene, the 1- and 8-positions are closer 
than substituents in the ortho position.  The substitution of the anthracene framework with 
phenyl groups incorporates an overall increase in steric hindrance.  Therefore, to prevent 
such bumping of substituents, the phenyls are forced into a propeller-like orientation, which 
tilts the phenyls out of plane.
118
  
 In addition to substitution, another way of inducing twist into the acene skeleton is 
through benzannulation.
118
  The fusion of benzo groups to the ends of the acene skeleton 
provides molecules with entirely different absorbance spectra due to the inclusion of 
additional conjugation.  One route to these structures has been the fusion of stable aromatics 
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(e.g., phenanthrene (87), pyrene (88), acenaphthene (89), and corannulene (90)) to the ends 
of acenes, as seen in Figure 37. 
 
 
 
 
Figure 37: Common acene end caps. 
 
 
 
The development of both single- and double-terminated unsubstituted acenes (91 and 92, 
respectively as depicted in Figure 38) has received some interest in hopes of offering 
protection from dimerization and oxidation, but has to this point has not solved the issue of 
stability.
122, 123
    
 
 
 
Figure 38: Single- and double-terminated unsubstituted acene structures 91-92, respectively. 
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Thus, this work has been overshadowed.  Used individually, substitution of acenes with 
bulky functional groups or benzannulation provides significant distortions to the acene 
skeleton.  However, the largest distortion has been observed on those compounds utilizing 
both ideas.
118
  Several compounds of varying length and structure have been synthesized and 
their deviation from planarity as defined by the ABCD torsion angle has been reported in the 
solid state (Figure 39 and Table 18).
124-127
   
 
 
 
 
Figure 39: Structures of crowded acenes.
124, 126
 
 
 
  
  
90 
 
 
Table 18: Twist of crowded acenes from solid state structures.
124,126
 
Compound Twist 
93 66º 
94 60º 
95 105º 
96 144º 
97 138º 
 
 
 
The largest end-to-end twists are attributed to clashing of the phenyls with the hydrogens of 
the benzo end groups.
118, 122
  Crystallographic analysis of 9,18-diphenyltribenzo 
[f,k,m]tetraphene (93) was found to have a twist of 66º, while the single terminated 
anthracene 94 was slightly smaller at 60º.
126, 128
  The addition of another benzene unit as in 
compound 95 increased the twist to 105º.
118
  The extension to longer acenes increases the 
twist to higher degrees.  Pentacenes 96 and 97 have end-to-end twists of 144º and 138º, 
respectively, with 96 currently being the most highly twisted PAH reported to date.
125
  All of 
the structures (Figure 12) are fluorescent compounds with increased stability in both air and 
light.  It is believed that even further extended acenes may be developed, but no synthetic 
pathways are currently reported in the literature.     
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Barrier to Enantiomerization 
 As discussed previously, the overall twist of acene skeletons have been attributed to 
substituent effects along the length of the acene.
118
  As a result of the twist, compounds, such 
as those given in Table 18 are chiral and exist in the solid.  Compounds with higher degree 
twists exhibit a stereochemistry similar to that observed in helicenes, molecules comprised of 
ortho-fused aromatic rings.
129
  The corkscrew conformation results from the repulsion of the 
faces of the rings as well as the steric-bulk of the groups required to interconvert from one 
enantiomeric conformation through the transition state to the other one.
126
  The minimum 
amount of energy required for this process is the barrier to enantiomerization.  Helicenes 
exhibit chirality without the presence of a stereogenic center.
130
  A “plus-minus” naming 
system was proposed by Cahn et al. by which  helicenes are labeled according to their left- 
(“minus”, M) and right- (“plus”, P) handedness, as seen in Figure 40.131       
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             P           M 
Figure 40: Handedness of [7] heptahelicene, “plus” (P) on left and “minus” (M) on right. 
 
 
 
In these molecules, the racemization process occurred quite easily as determined 
experimentally by H/D exchange which were placed on the ends of the molecule.
132
  It was 
determined that the interconversion was enabled by the twisting of the aromatic bonds of the 
molecule.  For helicenes, it was noted that conformational stability of individual racemates 
and the energy for the process as determined experimentally and computationally from [5] 
pentahelicene through [9] nonahelicene (~22.9 to 41.7 kcal/mol) (Table 19).
124, 132
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Table 19: Barrier to enantiomerization of helicenes. (Values listed in kcal/mol)
132
 
Compound Experimental AM1 B3LYP/3-21G 
[5] Pentahelicene  22.9 22.9 28.02 
[6] Hexahelicene 35.0 31.4 40.50 
[7] Heptahelicene 40.5 34.7 44.31 
[8] Octahelicene 41.0 34.9 43.38 
[9] Nonahelicene 41.7 34.0 40.80 
  
 
 
In the study, the calculated AM1 and B3LYP/3-21G values are useful in approximating the 
barrier to enantiomerization of helicenes in comparison to their experimental values.  A 
similar investigation of barriers to racemization has been utilized in acenes as well.  The 
helical twist of acenes has been thoroughly investigated through the use of X-ray 
crystallography and computational analysis.  Unfortunately, it is not possible to synthesize 
only one conformer because synthetic procedures yield racemates.
133
  Due to this inability to 
produce a single enantiomer the research focus has shifted towards the study and 
determination of the barrier through alternative means.  One such method has been the 
incorporation of a substituent which may act as a “handle” and able to monitor this 
conversion using Dynamic NMR Spectroscopy.
134-138
  It is well known that isopropyl groups 
are enantiotopic and can be utilized in an achiral environment to investigate the barriers using 
variable temperature NMR spectroscopy.  One such study by Pascal et al. reported that the 
racemic anthracene 93 has a twist of 66º.
126
  He and his co-workers prepared anthracene 98 
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which incorporated isopropyl groups at positions 9 and 10 of the anthracene skeleton (Figure 
41).     
 
 
 
 
Figure 41: Isopropyl substituted anthracene (98). 
 
 
 
Using Variable Temperature 
1
H NMR spectroscopy, the coalescence of the methyl groups 
was observed at 300 K.  Using the Gutowsky-Holm approximation (Eq. 1) and a standard 
propagation or error analysis (Eq. 2), the barrier was determined to be 16.7 kcal/mol.  The 
is the difference in frequency of the signals at the coalescence temperature, Tc and the 
coupling constant, Jab.
126, 139
  While the barrier is slow on the NMR timescale, it is much too 
low for the separation and isolation of the two enantiomers. 
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G = 4.576Tc(10.319 + log (Tc/kc))     Eq. 1 
       kc = 2 (ab
2
 + 6Jab
2
)
1/2
      Eq. 2 
 
 
 
Two additional methods have been used to determine the barrier of enantiomerization 
are to measure the half-life of a resolved compound by specific rotation or enantiomeric 
excess.
124
  Pascal et al. used both procedures to determine the barrier pentacene 96.  
Pentacene 96 was resolved by preparative HPLC with the specific rotation measured within 
minutes of peak elution.  The half-life for the decay of optical rotation was then recorded and 
determined to be 9.3 h at 25 ºC.  Additionally, the half-life for the loss of enantiomeric 
excess was determined to be 6.2 h at 27 ºC by HPLC analysis.  Both measurements resulted 
in a barrier of 23.8 kcal/mol.  Using all of these results, it was proposed that acenes, such as 
hexacene 99 (Figure 42) would be configurationally stable after separation at rt.
124
 
 
 
 
 
Figure 42: Phenanthrene terminated hexacene 99. 
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Objectives and Synthetic Approaches 
 The focus of the work by our group has been on the development of synthetic 
schemes for the extension of the acene backbone.  We have been able to prepare pentacene 
96 via an alternative synthesis from that of Pascal et al.
140
  They reported a five-step 
procedure with an overall yield of 2% (Figure 43, pathway a).
124
   In this procedure, 
diepoxide 102 was formed by reacting compound 101 with furan 100 in the presence of n-
butyllithium in a 26% yield.  Deoxygenation was then accomplished using n-butyllithium 
and TiCl3 to give 96 as a bright red solid in a 27% yield (0.2% overall synthetic yield).  
  
 
9
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Figure 43: Synthetic routes for 96, pathway a 0.2% overall yield, pathway b 36.7% overall yield. Conditions: a) n-BuLi, hexanes, 
toluene, 26%; b) n-BuLi, TiCl3, ether, hexanes, 27%; c) 1,3-diphenylacetone, ethanol, NaOH, 85%; d) p-benzoquinone, nitrobenzene, 
51% and e) (i) PhLi, THF, 91% (ii) TiCl2, THF, HCl, 72%. 
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Our alternative synthesis of 96 (Figure 43, pathway b) required four steps and 
resulted in an overall yield of 36.7%.  In this pathway, two equivalents of cyclone 104 were 
reacted with p-benzoquinone in a Diels-Alder reaction to give quinone 105 in a yield of 51%.  
Reduction of 105 to the diol was then accomplished by the addition of two equivalents of 
phenyllithium in a 91% yield.  The aromatized product was then formed by reduction using 
TiCl2 to give pentacene 96 in 72% yield.  Therefore, the use of a simple Diels-Alder reaction 
followed by lithium reductions provided an efficient synthetic route to a highly crowded 
pentacene.  Using this methodology, our group was able to develop the symmetric double 
pyrene terminated pentacene 97, along with the asymmetric phenanthrene-pyrene terminated 
pentacene 97 as seen in Figure 44.  
 
 
 
 
Figure 44: Pyrene terminal pentacene 97 and phen-pyrene pentacene 106. 
 
 
 
For the cases in which a pyrene endcap was utilized, oxidation of pyrene (88) to the 4,5-
dione (107) was required (Figure 45).
141
  Once the dione was obtained, pathway b (Figure 
43) was followed according to the same procedures used for phenanthrene endcaps. 
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Figure 45: Oxidation of pyrene.  
 
 
 
This pathway provides a roadmap in the synthesis of acenes with alternative end groups and 
substituents. 
 The goal of this study was to synthesize novel acenes derived from pentacene 96 
using the synthetic pathway previously developed by our group (pathway b, Figure 43).  
Derivatization of pentacene 96 was focused on three specific areas: 1) the addition of 
alternative end groups to the acene skeleton, 2) the functionalization of the acenes with 
isopropyl groups, a possible Variable-Temperature NMR spectroscopic probe for the 
determination of the barrier to enantiomerization, and 3) the extension of the acene skeleton. 
Results and Discussion 
 The development of the reducibility of acene quinones using phenyllithium allowed 
for the pursuit of a variety of synthetic strategies.   
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Corannulene 
In this investigation of endcaps the first choice was corannulene (90).  
Functionalization of corannulene was centered on its use for larger structures including 
carbon nanotubes.
142-145
  However, as far as we know corannulene has not been used as an 
endcap in the development of extended acenes.  In order to follow our established 
methodology, oxidation of corannulene to the dione was the first necessary step in this 
synthetic pathway (Figure 46).
146
 
 
 
 
 
Figure 46: Development of corannulene endcap. Conditions: a) CH3CN, ammonium cerium 
sulfate, H2SO4, 35%; b)  EtOH, NaOH, rt, 15 min, 0%. 
 
 
Thus, corannulene dione 108 was synthesized through the oxidation of 90 using ammonium 
cerium sulfate and H2SO4 (35% yield).
146
  From there, numerous trials to form cyclone 109 
via the aldol condensation using 1,3-diphenylacetone were unsuccessful using an array of 
bases, including NaOH, KOH, and Triton B (benzyltrimethylammonium hydroxide).  
Reactions were run varying the temperature (rt to 100 °C for 1 h) with no formation of the 
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desired product as determined by 
1
H NMR.  After numerous attempts, no feasible route to 
cyclone 109 was discovered, and the development of a corannulene endcap was discontinued. 
Use of Pyrene as a Central Unit 
 As discussed previously, pyrene has been utilized as endcaps for acenes.  The first 
step in the synthesis is the oxidation of pyrene 88 to the 4,5-dione 107 (Figure 45).
141
  
Having already successfully developed a synthetic route of pyrene as an endcap, the 
oxidation of the C4, C5, C9, and C10 positions to the tetraone was proposed.  Disubstitution 
would allow for expansion on both sides of pyrene rather than just at the C4 and C5 
positions.  However, there are solubility issues with planar structures.  In our previous work, 
we added tert-butyl groups to increase solubility and enable solvent chemistry.  Using this 
approach tert-butyl groups were first added to the C2 and C7 positions of pyrene (Figure 
47).
147
   
 
 
 
Figure 47: Attempted synthesis of central pyrene acene.  Conditions: a) AlCl3, t-
butylchloride, 79%; b) CH2Cl2, CH3CN, H2O, NaIO4, RuCl3·H2O, 17%; c) 1,3-
diphenylacetone, NaOH, 0%. 
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Di-t-butyl pyrene 110 was then oxidized to quinone 111 using the same procedure as for the 
2,7-dione, but with two equivs. of ruthenium chloride while heating to 60 ºC.
141
  From there, 
the synthesis of dicyclone 112 was attempted through the aldol condensation with 1,3-
diphenylacetone.  In the case of the corannulene endcap, reactions to make the cyclone 
equivalent were unsuccessful.  As with corannulene, the reaction attempts to form cyclone 
112 were unsuccessful.  This approach included a variety of bases (e.g., NaOH, KOH, and 
Triton B), temperatures (rt to 100 °C), and reaction times (15 min to 3 h).  Further attempts to 
synthesize a central pyrene unit were discontinued.  
Isopropyl Derivatives 
 The investigation into the barrier of enantiomerization of our acenes was focused on 
the incorporation of a substituent capable of studies by Variable-Temperature NMR 
spectroscopy.  The probe selected for the investigation was that of an isopropyl group as in 
the case of anthracene 98 previously synthesized by Pascal.
126
  For this investigation, target 
compounds of pentacene 113 and anthracene 115 were selected (Figure 48).  It was proposed 
that the barrier to enantiomerization would be between 23-24 kcal/mol for 113 and 16-18 
kcal/mol for 115.  These proposals were based upon the calculated values for corresponding 
compounds 96 (23.8 kcal/mol) and 97 (16.7 kcal/mol), respectively.
118
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Figure 48: Retrosynthetic analysis of isopropyl acenes. 
 
 
 
In both cases, the fully aromatized compounds were synthesized from the quinone precursor 
(114 and 116, respectively).   
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Pyrene Isopropyl Pentacene 
 Synthesis of pentacene 113 was performed mirroring the methodology used for 
pathway b in Figure 17.  Quinone 114 was obtained in a four-step process beginning with the 
oxidation of pyrene to dione 107 in 36% yield (Figure 49). 
 
 
 
 
Figure 49: Synthesis of pyrene pentacene quinone. Conditions: a) CH2Cl2, CH3CN, H2O, 
NaIO4, RuCl3·H2O, 36%; b) 1,3-diphenylacetone, NaOH, EtOH, 59%; c) p-benzoquinone, 
nitrobenzene, 58%; d) cyclone 117, nitrobenzene, 59%. 
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Cyclone 117 was then obtained through the aldol condensation of dione 107 with 1,3-
diphenylacetone (59% yield).  A solution of cyclone 117 and benzoquinone was refluxed 1 h 
in nitrobenzene which afforded quinone 118 as a red-orange solid in 58% yield.  Then 
pentacene quinone 114 was obtained through an additional Diels-Alder reaction which 
entailed refluxing quinone 118 and cyclone 117 in nitrobenzene for 24 h.  The resulting green 
solid (59% yield, 7.2% overall yield) was highly insoluble in organic solvents and required 
no further purification.   
 The ability to reduce quinone 114 to the diol using phenyllithium, followed by 
reduction to the aromatized acene, enabled exploration into the possibility of further 
substituted materials.  One way to measure the barrier to enantiomerization as previously 
described by Pascal is to incorporate isopropyl handles at some point during the synthesis.
126
  
Therefore, an isopropyl organolithium reagent was utilized in the reduction of quinone 114 in 
lieu of phenyl lithium using a procedure adapted from Miller et al.
92
  The isopropyl adduct 
was produced by the slow addition of n-butyllithium to a solution of 1-bromo-4-
isopropylbenzene and THF at -78 °C (Figure 50).   
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Figure 50: Synthesis of pyrene isopropyl pentacene 113. Conditions: a) n-BuLi, THF, 1-
bromo-4-isopropylbenzene, 46%; b) THF, SnCl2•2 H2O, HCl, 40%. 
 
 
 
After stirring at -78 °C for a minimum of 20 min, the cloudy solution was warmed until it 
became clear.  Then, the isopropyl lithium adduct was added to a stirring suspension of 
quinone 114 in THF.  Upon addition, the green suspension turned a deep red color and was 
stirred at rt for 24 h.  The reaction solution was quenched with an acid water and yielded diol 
119 as a yellow solid in 46% yield.  Aromatization was then achieved by the reduction of 
diol 119 to pentacene 113 using tin (II) chloride and HCl in THF.  The red-orange solid was 
collected by filtration after recrystallization from CHCl3‒MeOH in a 40% yield (1.3% 
overall yield).  The pentacene was characterized by mass spectrometry, 
1
H and 
13
C NMR 
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spectroscopy, and X-ray crystallography of crystals grown in CHCl3‒MeOH.  Analysis of the 
crystal structure revealed the end-to-end twist of the molecule to be 126º (Figure 51 and 
Table 20).  In comparison to compound 97 (138º) there was a decrease in the overall twist of 
the compound upon the addition of isopropyl substituents.  
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Figure 51:  X-ray crystal structures of pyrene isopropyl pentacene 113 displaying the end-to-
end twist (126º) of the acene skeleton. 
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Table 20: Crystal data for Compound 113, C86H56 (2), CCl4O2   
Compound C86H56 (2), CCl4O2 
Chemical Formula C169H112Cl4O2 
Formula weight 2316.39 
Crystal system Tetragonal 
Space group  P 4/n 
a, Å 19.8596(16) 
b, Å 19.8596(16) 
c, Å 15.1473(13) 
 deg 90 
 deg 90 
 deg 90 
V, Å
3
 5972.5(11) 
Z 2 
 calcd g cm-3 1.288 
crystal size 0.26 x 0.08 x 0.07 
µ, mm
-1
 0.160 
T, K 100(2) 
F(000) 2420.0 
max, deg 22.500 
Reflections 
   Total 73056 
  Unique 3915 
  observed [I > 2s(l)] 2404 
Rint 0.1701 
Parameters 398 
R(F) (obs data)
a
 0.0941 
wR(F
2
) (obs data)
a
 0.2940 
R(F) (all data)
a 
0.0941 
wR(F
2
) (all data)
a 
0.2940 
S (all data)
a
 1.025 
a
R(F) = ||Fo| - | Fc||/| Fo|;wR(F
2
) = [w(Fo
2
 – Fc
2
)
 2
/w(Fo
2
)
2
]
1/2
; S = goodness of fit on F
2
 = 
[w(Fo
2
 – Fc
2
)
 2
/(n – p)]1/2, where n is the number of reflections and p is the number of 
parameters refined. 
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Table 21: Atomic coordinates and equivalent isotropic displacement parameters for 113. 
Atom        x        y        z       Ueq 
C1 0.2200(3) 1.0084(3) 0.4180(4) 0.0439(15) 
C2 0.2097(3) 1.0709(3) 0.4571(4) 0.0478(16) 
C3 0.1777(3) 1.1211(3) 0.4121(4) 0.0477(16) 
C4 0.1200(3) 1.1625(3) 0.2786(5) 0.0520(18) 
C5 0.0969(3) 1.1515(3) 0.1969(5) 0.0559(18) 
C6 0.0732(3) 1.0744(3) 0.0738(4) 0.0536(17) 
C7 0.0776(3) 1.0114(3) 0.0377(4) 0.0515(17) 
C8 0.1045(3) 0.9577(3) 0.0845(4) 0.0414(15) 
C9 0.1500(3) 0.8421(3) 0.2052(4) 0.0336(13) 
C10 0.3168(3) 0.7759(2) 0.2563(3) 0.0343(14) 
C11 0.2623(3) 0.8862(2) 0.3046(4) 0.0353(14) 
C12 0.1523(3) 1.1095(3) 0.3281(4) 0.0383(14) 
C13 0.0993(3) 1.0857(3) 0.1578(4) 0.0469(16) 
C14 0.1300(3) 1.0317(3) 0.2051(4) 0.0361(14) 
C15 0.1299(3) 0.9655(3) 0.1694(4) 0.0334(14) 
C16 0.1609(3) 0.9107(3) 0.2196(4) 0.0338(14) 
C17 0.1959(3) 0.7931(2) 0.2442(3) 0.0326(13) 
C18 0.2601(3) 0.8181(2) 0.2685(4) 0.0340(14) 
C19 0.2098(3) 0.9295(2) 0.2879(4) 0.0340(13) 
C20 0.1984(3) 0.9946(3) 0.3333(4) 0.0353(14) 
C21 0.1599(3) 1.0450(2) 0.2888(4) 0.0353(14) 
C22 0.1011(3) 0.8145(2) 0.1399(4) 0.0339(14) 
C23 0.0319(3) 0.8189(3) 0.1506(4) 0.0411(15) 
C24 -0.0110(3) 0.7925(3) 0.0873(4) 0.0480(16) 
C25 0.0142(3) 0.7631(3) 0.0133(4) 0.0503(17) 
C26 0.0835(3) 0.7589(3) -0.0003(4) 0.0408(15) 
C27 0.1257(3) 0.7835(2) 0.0636(4) 0.0349(14) 
C28 0.3856(3) 0.8038(2) 0.2556(4) 0.0349(14) 
C29 0.4028(3) 0.8568(3) 0.1981(4) 0.0441(15) 
C30 0.4659(3) 0.8840(3) 0.2000(4) 0.0555(18) 
C31 0.5144(3) 0.8616(3) 0.2568(4) 0.0544(18) 
C32 0.4984(3) 0.8084(3) 0.3128(4) 0.0489(16) 
C33 0.4349(3) 0.7804(3) 0.3127(4) 0.0384(14) 
C34 0.3166(3) 0.9003(3) 0.3708(4) 0.0355(14) 
C35 0.3193(3) 0.8606(3) 0.4469(4) 0.0412(15) 
C36 0.3650(3) 0.8738(3) 0.5118(4) 0.0511(17) 
C37 0.4098(3) 0.9262(4) 0.5026(5) 0.061(2) 
Table continued    
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Table 21 continued    
Atom        x        y       z     Ueq 
C38 0.4081(3) 0.9657(3) 0.4288(5) 0.061(2) 
C39 0.3617(3) 0.9532(3) 0.3623(4) 0.0458(16) 
C40 0.5837(4) 0.8957(4) 0.2570(5) 0.072(2) 
C41 0.6038(11) 0.9253(12) 0.3450(10) 0.080(6) 
C42 0.6422(9) 0.8438(9) 0.2686(18) 0.095(7) 
C51 0.6344(13) 0.8470(12) 0.221(3) 0.097(9) 
C52 0.5799(11) 0.9492(11) 0.3349(11) 0.046(6) 
 
 
 
Isopropyl Anthracene 
 The second isopropyl derivative studied was anthracene 115.  Addition of a phenyl 
isopropyl substituent was made possible by the availability of anthraquinone 116, which had 
previously been developed by Kilway et al. through the Diels-Alder reaction of thiophene 
111 and benzoquinone 112 (Figure 52).
127
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Figure 52: Synthetic scheme for isopropyl anthracene 115.  Conditions: a) nitrobenzene, 
reflux, 12%; b) n-BuLi,1-bromo-4-isopropylbenzene, THF, benzene, 35.6% crude; c) THF, 
SnCl2•2 H2O, HCl, 2.3%. 
 
 
 
Reduction of the quinone was again achieved by in situ formation of the lithium isopropyl 
phenyl adduct at -78 ºC in THF and n-butyllithium.  Once formed, the lithium adduct was 
then added to a refluxing solution of anthraquinone 116 in benzene.  The resulting dark green 
solution was refluxed for an additional 1 h followed by stirring for 24 h at rt.  Acid workup of 
the solution resulted in diol 121 as a brown solid.  A final reduction to anthracene 115 was 
achieved by the addition of tin chloride and HCl to a stirring solution of the diol and THF at 
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a gentle reflux.  Within minutes of addition, the solution became a dark green color and was 
heated for an additional 20 min.  Filtration and purification resulted in isopropyl anthracene 
115 as a green solid, which was verified by 
1
H and 
13
C NMR spectroscopy (2.3% yield, 0.9% 
overall yield).   
UV Studies 
Pentacene 113 is soluble in polar solvents, such as chloroform and methylene 
chloride, and exhibits a dark orange hue when dissolved in chloroform (Figure 53 light).  
Under UV irradiation (wavelength: 365 nm), the solution emits a bright orange fluorescence 
(Figure 53 dark).    Anthracene 115 is soluble in polar solvents as well but, becomes a dark 
green solution when dissolved in chloroform (Figure 53).  Under UV irradiation at 365 nm, 
the solution exhibits no fluorescence.   
 
 
 
  
Figure 53: Pyrene isopropyl pentacene 113 (3.5 x 10
-5
 M left and middle) in CDCl3 in light 
and under UV Isopropyl and anthracene 115 (1.7 x 10
-5
 M, right) under regular light. 
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113 was studied using UV-Vis spectroscopy resulting in absorbances at 422, 491, 515, and 
551 nm.  The longest max was determined to be 551 nm, which was similar to the parent 
compound 97 (max of 553 nm).  The extinction coefficient was determined to be 50772 for 
max of 422 nm using dilution studies (from 2.27x10
-5
 to 1.45x10
-6
 M, see Figure 54).   
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Figure 54: UV-Vis spectral dilution studies for pyrene isopropyl pentacene 104. 
 
 
 
 
 
Figure 55: UV-Vis spectral dilution studies for isopropyl anthracene 115 in CHCl3. 
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Anthracene 115 was studied in CHCl3 using UV-Vis spectroscopy resulting in max of 
380, 477, 501, 644, and 693 nm.  The longest max was determined to be 693 nm which was 
similar to the parent compound 122 (max of 690 nm, Figure 55).     
 
 
 
Figure 56: Phenylated anthracene 122. 
 
 
 
The extinction coefficient was determined to be 69295 for max of 379 nm using 
dilution studies (from 1.32x10
-5
 to 6.39x10
-7
 M, see Figure 55).  In comparison, the 
extinction coefficient of parent compound 122 was determined to be 82045. 
In comparing the spectral properties of the newly synthesized isopropyl compounds 
in relation to the parent phenylated compounds, a hypsochromic shift of 2 nm was observed 
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for the pyrene derivatives, while a bathochromic shift of 3 nm was observed for the 
anthracene compounds (Table 21). 
 
 
Table 22: Comparison of isopropyl to parent compounds. 
Compound max (nm) 
Exctinction  
coefficient 
113, isopropyl 551 50772 
97 553 Not determined 
115, isopropyl 693 69295 
122 690 82045 
 
 
 
The extinction coefficient for 97 was not collected in the experiment, but a decrease of nearly 
13000 was observed by the addition of an isopropyl substituent to 115 in comparison to 122.  
A more detailed study comparing a larger series of phenylisopropyl derivatives to the parent 
phenyl compounds would allow for a closer determination of the effect of the added 
functionalization. 
Variable-Temperature NMR Studies 
 As previously mentioned, Pascal et al. used the enantiotopic isopropyl groups and the 
Gutowsky-Holm approximation to estimate the barriers of racemization in his twisted 
sterically bulky acenes.
126
  For a typical Ph-CH(CH3)2 group, the 
1
H NMR spectrum would 
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exhibit a splitting pattern of a doublet for the methyl groups which are split by the methine 
proton and a septet for the methine proton due to the six protons of the methyl groups. These 
signals can be decoupled and would thus be observed as two singlets.  Since the two 
isopropyl groups are enantiotopic, they would be split into two pairs of doublets in the event 
of slow exchange (e.g., slow interconversion between two chiral environments) because they 
are now diastereotopic.  Two doublets would be observed in the decoupled 
1
H NMR 
spectrum.  For rapid interconversion, the signals would be a doublet for the two the averaged 
diastereotopic methyl groups.  Compounds 113 and 115 were purified as determined by 
1
H 
and 
13
C NMR spectra and submitted to Variable-Temperature 
1
H NMR experiments.  In 
order to approximate the barrier, it is necessary to observe coalescence (rapid exchange on 
the NMR timescale) and baseline separation of the signals at the low and high temperatures 
   At 294 K in CDCl3, the two sets of decoupled doublets are resolved, indicating the 
fast interconversion between the helical conformations.  With an increase in temperature to 
328 K, which was the upper limit for this experiment due to the boiling point for chloroform, 
coalescence of the two signals was not observed.  In fact, the two sets of signals were still 
separated and resolved.  Therefore, it was necessary to switch to a deuterated solvent with a 
higher boiling point but with signals, which do not interfere with isopropyl signals.  Thus, 
1,1,2,2-tetrachloroethane-d2 (C2Cl4D2; b.p. 418K) was chosen as a suitable next solvent.  
1
H 
NMR spectra were collected at temperatures from 293 K – 408 K (Figure 57) 
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Figure 57: 
1
H Variable-Temperature NMR spectra of pyrene isopropyl pentacene 113. 
 
 
 
As in the case with CDCl3 as the solvent, no coalescence of the isopropyl signals was 
observed.  There were small shifts for the resonances due to temperature and solvent effects.  
When the actual coupling for the splitting of the signals was compared over the temperature 
293 K 
323 K 
375 K 
343 K 
363 K 
408 K 
393 K 
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range, there was a small decrease (0.8 Hz) starting with 2.4 Hz to 1.6 Hz for 293 K and 408 
K, respectively.  Unfortunately, since there was no rapid exchange observed, it indicates that 
higher temperatures are required to determine the barrier for this exchange. 
 In the case of compound 115, the same investigation was carried out using Variable-
Temperature NMR spectroscopy (Figure 58).   
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Figure 58: 
1
H Variable-Temperature NMR spectra of isopropyl anthracene 115. 
 
 
 
As in the case of 113, the doublets from the diastereotopic methyl groups were clearly 
resolved at 293 K and still observed at 408 K.  Therefore, it was not possible to determine the 
barrier for interconversion since the coalescence of the two groups was not observed.  It was 
293 K 
343 K 
388 K 
353 K 
363 K 
408 K 
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noted that there was an overlapping of doublets (388-408 K) in the spectrum of 115.  This 
change is temperature dependent as noted by the merging of the internal “middle” signals 
with increasing temperatures.  There was also a decrease in the coupling constant of 0.8 Hz 
from 293 K (6.8 Hz) to 408 K (6.0 Hz).  At 408 K, the upper limit for the solvent and 
coalescence was not observed, the barrier of racemization for both 115 and 113 can be 
estimated to be greater than 24 kcal/mol.  Further variable-temperature NMR studies using 
this approach are not possible in this solvent (C2Cl4D2) due to its boiling point, the upper 
temperature limit of the probe, and insolubility of acenes in higher boiling-point solvents 
(DMSO-d6).  While this is the case, it may be possible to use other VT NMR experiments 
including 2D NMR techniques to determine the barriers in these systems.
148
     
Extension of the Acene Skeleton 
 The extension of the acene skeleton has proven to be a difficult task due to factors 
such as solubility and stability.
118
  Additionally, the development of viable synthetic 
pathways has also been a challenge to this point.  However, recently our group was able to 
develop preliminary schemes which build upon the acene skeleton of 96 and extend it from a 
pentacene to hexacene 99 (Figure 59).   
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Figure 59: Phenanthrene endcapped hexacene 99. 
 
 
In a followup to that approach, the pyrene endcapped derivative was attempted.  As in the 
synthesis of 97, cyclone 117 was obtained from the oxidation and subsequent aldol 
condensation of pyrene.  As a means of extending the skeleton, an intermediate was required 
which would allow for extension of the benzene bridge while retaining the dienophile 
required to complete subsequent Diels-Alder reactions to add the corresponding end cap.  
Naphthazarin (125) was identified and synthesized from the procedure by Toribara (Figure 
60).
149, 150
      
 
 
 
 
Figure 60: Synthesis of naphthazarin intermediate. Conditions: a) NaCl, AlCl3, HCl, 17.2%;  
b) acetic anhydride, pyridine, 56.6%. 
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Naphthazarin (125) was then converted to acetate 126 using acetic anhydride and pyridine.  
The yellow acetate intermediate had the ability to undergo a Diels-Alder reaction while 
retaining the potential for further reactions to the adjacent end of the compound while 
extending the backbone.  From there, the acetate was heated to 180 ºC for 24 h with cyclone 
117 to give quinone 127 (Figure 61). 
 
 
 
 
Figure 61: Schematic for the synthesis of pyrene hexacene quinone 129.  Conditions: a) 
nitrobenzene, 39.5%; b) PhLi, THF, nitrobenzene, 30.6%; c) cyclone 117, nitrobenzene, 
36.0%. 
 
 
 
Reduction of quinone 127 using phenyllithium followed by refluxing in nitrobenzene 
produced the red quinone 128.  A final Diels-Alder reaction with incremental additions of 
cyclone 117, followed by heating to 180 ºC in nitrobenzene for 65 h, produced the pyrene 
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terminal hexacene quinone 129 as a brown solid (36.0% yield).  Reduction of quinone 129 
was then accomplished by the addition of phenyllithium at rt. (Figure 62).  
 
 
  
 
Figure 62: Schematic of preliminary steps for the formation of pyrene hexacene diol 130. 
 
 
Acid workup of the reaction gave diol 130 as a brown solid (74.7% crude yield).  Quinone 
129 and diol 130 were characterized using X-ray crystallographic analysis (Figures 63 and 
64, respectively and Table 22).  
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Figure 63: Crystal structure of pyrene hexacene quinone 129. 
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Figure 64: Crystal structures of pyrene hexacene diol 130. 
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Table 23: Crystal data for compounds 129 and 130. 
Compound C82H46, C6H5Br C94H58O2, CHCl3 
Chemical Formula C88H51BrO2 C95H59Cl3O2 
Formula weight 1220.19 1338.77 
Crystal system Triclinic Monoclinic 
Space group  P -1  P21/n 
a, Å 11.1846(5) 12.7289(7) 
b, Å 13.1615(5) 26.4201(15) 
c, Å 22.2777(9) 20.5383(11) 
 deg 91.511(1) 90.00 
 deg 104.029(1) 102.9300(10) 
 deg 111.100(1) 90.00 
V, Å
3
 2944.8(2) 6731.9(6) 
Z 2 4 
 calcd g cm-3 1.376 1.321 
crystal size 0.21 x  0.15 x  0.02 0.26 x  0.14 x  0.05 
µ, mm
-1
 0.754 0.192 
T, K 99(2) 100(2) 
F(000) 1260.0 2784.0 
max, deg 30.660 28.700 
Reflections 
 
 
  Total 18126 149839 
  Unique 3915 17392 
  observed [I > 2s(l)] 2404 8461 
Rint 0.1188 0.2019 
Parameters 820 938 
R(F) (obs data)
a
 0.0651 0.0780 
wR(F
2
) (obs data)
a
 0.1132 0.1800 
R(F) (all data)
a 
0.1439 0.1928 
wR(F
2
) (all data)
a 
0.1375 0.1461 
S (all data)
a
 0.982 1.116 
a
R(F) = ||Fo| - | Fc||/| Fo|;wR(F
2
) = [w(Fo
2
 – Fc
2
)
 2
/w(Fo
2
)
2
]
1/2
; S = goodness of fit on F
2
 = 
[w(Fo
2
 – Fc
2
)
 2
/(n – p)]1/2, where n is the number of reflections and p is the number of 
parameters refined. 
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Table 24: Atomic coordinates and equivalent isotropic displacement parameters for 129. 
Atom x y Z Ueq 
O1 0.20239(16) 0.99603(14) 0.17113(8) 0.0154(4) 
O2    0.68337(16)    1.00181(14)    0.25160(8)    0.0159(4) 
C1 0.6859(2) 1.0838(2) 0.00574(11) 0.0132(5) 
C2 0.7441(2) 1.1078(2) -0.04323(11) 0.0153(5) 
C3 0.7722(2) 1.2090(2) -0.06422(12) 0.0174(5) 
C4 0.7671(3) 1.3965(2) -0.05781(14) 0.0244(6) 
C5 0.7378(3) 1.4733(2) -0.03055(14) 0.0257(7) 
C6 0.6409(3) 1.5294(2) 0.04736(14) 0.0232(6) 
C7 0.5746(3) 1.5040(2) 0.09288(13) 0.0232(6) 
C8 0.5301(3) 1.3978(2) 0.10805(13) 0.0189(6) 
C9 0.4178(2) 1.16153(19) 0.12955(11) 0.0119(5) 
C10 0.3192(2) 1.01784(19) 0.19726(11) 0.0127(5) 
C11 0.2925(2) 0.95778(19) 0.30129(11) 0.0118(5) 
C12 0.2769(2) 0.88607(19) 0.40495(11) 0.0123(5) 
C13 0.2829(3) 0.8890(2) 0.54427(12) 0.0199(6) 
C14 0.2790(3) 0.8843(2) 0.60626(12) 0.0230(6) 
C15 0.2522(3) 0.7873(2) 0.63077(13) 0.0231(6) 
C16 0.1900(3) 0.5871(2) 0.61786(13) 0.0253(6) 
C17 0.1517(3) 0.4918(2) 0.58081(13) 0.0260(7) 
C18 0.1131(3) 0.3931(2) 0.47767(14) 0.0228(6) 
C19 0.1206(3) 0.3952(2) 0.41704(13) 0.0221(6) 
C20 0.1760(3) 0.4944(2) 0.39449(13) 0.0191(6) 
C21 0.3482(2) 0.7155(2) 0.36403(11) 0.0135(5) 
C22 0.4717(2) 0.84844(19) 0.29880(11) 0.0118(5) 
C23 0.5672(2) 0.98685(19) 0.22834(11) 0.0118(5) 
C24 0.6042(2) 1.06160(19) 0.12888(11) 0.0112(5) 
C25 0.7385(2) 1.2891(2) -0.03764(12) 0.0167(5) 
C26 0.6705(3) 1.4499(2) 0.01782(13) 0.0197(6) 
C27 0.5554(2) 1.3150(2) 0.07948(12) 0.0144(5) 
C28 0.5197(2) 1.20478(19) 0.09854(11) 0.0124(5) 
C29 0.4258(2) 1.07970(19) 0.16735(11) 0.0125(5) 
C30 0.3585(2) 0.96980(19) 0.25523(11) 0.0116(5) 
C31 0.3150(2) 0.88768(19) 0.34771(11) 0.0123(5) 
C32 0.2697(2) 0.7977(2) 0.43927(11) 0.0141(5) 
C33 0.2585(2) 0.7952(2) 0.50438(12) 0.0145(5) 
C34 0.2273(3) 0.6910(2) 0.59367(13) 0.0217(6) 
C35 0.1552(3) 0.4911(2) 0.51673(13) 0.0210(6) 
Table continued    
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Table 24 Continued    
Atom x y Z Ueq 
C37 0.2035(3) 0.5936(2) 0.49291(12) 0.0166(5) 
C38 0.2213(2) 0.5946(2) 0.43198(12) 0.0162(5) 
C39 0.2806(2) 0.7024(2) 0.41025(11) 0.0138(5) 
C40 0.3792(2) 0.81609(19) 0.33659(11) 0.0123(5) 
C41 0.4623(2) 0.9288(2) 0.26006(11) 0.0124(5) 
C42 0.5315(2) 1.04228(19) 0.17304(11) 0.0125(5) 
C43 0.5931(2) 1.14045(19) 0.08804(11) 0.0114(5) 
C44 0.6539(2) 1.16171(19) 0.03543(11) 0.0116(5) 
C45 0.6750(2) 1.2639(2) 0.01144(12) 0.0148(5) 
C46 0.6331(2) 1.3433(2) 0.03594(12) 0.0147(5) 
C47 0.3006(2) 1.19470(19) 0.11586(12) 0.0140(5) 
C48 0.2290(3) 1.1835(2) 0.05361(12) 0.0170(5) 
C49 0.1163(3) 1.2092(2) 0.03777(13) 0.0211(6) 
C50 0.0750(3) 1.2489(2) 0.08411(14) 0.0217(6) 
C51 0.1454(3) 1.2609(2) 0.14600(13) 0.0203(6) 
C52 0.2570(2) 1.2337(2) 0.16158(13) 0.0176(5) 
C53 0.1967(2) 1.0138(2) 0.29948(11) 0.0132(5) 
C54 0.0611(2) 0.9528(2) 0.28882(12) 0.0159(5) 
C55 -0.0276(3) 1.0050(2) 0.28645(12) 0.0191(6) 
C56 0.0178(3) 1.1179(2) 0.29435(12) 0.0202(6) 
C57 0.1526(3) 1.1797(2) 0.30457(12) 0.0199(6) 
C58 0.2414(3) 1.1278(2) 0.30698(12) 0.0162(5) 
C59 0.2678(2) 0.9896(2) 0.42866(11) 0.0130(5) 
C60 0.1494(3) 0.9967(2) 0.43481(12) 0.0188(6) 
C61 0.1494(3) 1.0968(2) 0.45661(12) 0.0237(6) 
C62 0.2661(3) 1.1891(2) 0.47319(12) 0.0239(6) 
C63 0.3836(3) 1.1830(2) 0.46755(12) 0.0218(6) 
C64 0.3834(3) 1.0837(2) 0.44464(12) 0.0175(5) 
C65 0.3827(3) 0.6259(2) 0.34012(12) 0.0178(5) 
C66 0.4635(3) 0.5820(2) 0.37992(15) 0.0246(6) 
C67 0.4954(3) 0.4988(2) 0.35762(18) 0.0362(8) 
C68 0.4447(3) 0.4571(2) 0.29501(18) 0.0395(9) 
C69 0.3641(3) 0.4987(2) 0.25480(16) 0.0350(8) 
C70 0.3341(3) 0.5834(2) 0.27727(13) 0.0230(6) 
C71 0.5815(2) 0.8078(2) 0.30563(12) 0.0143(5) 
C72 0.6687(2) 0.8216(2) 0.36431(12) 0.0180(6) 
Table continued    
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Table 24 continued    
Atom x y Z Ueq 
C74 0.7918(3) 0.7364(2) 0.32192(14) 0.0237(6) 
C75 0.7063(3) 0.7225(2) 0.26306(14) 0.0237(6) 
C76 0.6016(3) 0.7579(2) 0.25496(13) 0.0178(5) 
C77 0.6872(2) 0.99597(19) 0.12579(11) 0.0118(5) 
C78 0.6238(3) 0.8826(2) 0.11100(12) 0.0184(6) 
C79 0.6968(3) 0.8190(2) 0.10574(13) 0.0266(7) 
C80 0.8337(3) 0.8679(3) 0.11573(13) 0.0274(7) 
C81 0.8975(3) 0.9802(2) 0.13062(12) 0.0219(6) 
C82 0.8243(2) 1.0442(2) 0.13580(11) 0.0159(5) 
C83 0.9350(3) 0.4755(2) 0.20770(13) 0.0199(6) 
C84 0.9313(3) 0.5071(2) 0.14869(13) 0.0255(6) 
C85 0.9785(3) 0.6180(2) 0.14269(14) 0.0294(7) 
C86 1.0310(3) 0.6964(2) 0.19474(13) 0.0226(6) 
C87 1.0337(3) 0.6627(2) 0.25291(13) 0.0218(6) 
C88 0.9847(3) 0.5525(2) 0.26004(13) 0.0201(6) 
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Table 25: Atomic coordinates and equivalent isotropic displacement parameters for 130. 
Atom x y Z Ueq 
O1 0.3574(2) 0.70525(8) 0.4379(11) 0.0249(5) 
O2    0.1940(2)    0.66293(8)     0.64126(10)    0.0211(5) 
C1 0.0125(3) 0.96397(12) 0.5928(2) 0.0283(8) 
C2 -0.0185(3) 1.01227(13) 0.6075(2) 0.0355(9) 
C3 -0.1155(3) 1.03165(14) 0.5719(2) 0.0408(10) 
C3A -0.1792(3) 1.00485(13) 0.5196(2) 0.0365(9) 
C4 -0.2792(3) 1.0246(2) 0.4810(2) 0.0516(12) 
C5 -0.3383(3) 0.9992(2) 0.4290(2) 0.0509(12) 
C5A -0.3028(3) 0.5173(14) 0.4078(2) 0.0332(8) 
C6 -0.3620(3) 0.92622(14) 0.3518(2) 0.0368(9) 
C7 -0.3255(3)  0.88102(14)  0.3323(2)  0.0314(8) 
C8 -0.2279(3) 0.86098(13) 0.3667(2) 0.0270(8) 
C8A -0.1633(2) 0.88556(12) 0.4213(2) 0.0217(7) 
C8B -0.0595(2) 0.86506(11) 0.4589(2) 0.0198(7) 
C9 0.0023(2) 0.82913(11) 0.4342(2) 0.0195(6) 
C9A 0.0884(2) 0.80445(11) 0.47886(15) 0.0176(6) 
C10 0.1772(2) 0.77832(11) 0.45955(15) 0.0180(6) 
C10A 0.2374(2) 0.74486(11) 0.50333(15) 0.0166(6) 
C11 0.3524(2) 0.72831(11) 0.50022(15) 0.0189(6) 
C11A 0.3945(2) 0.68408(11) 0.54805(15) 0.0170(6) 
C12 0.5028(2) 0.66905(11) 0.56033(14) 0.0175(6) 
C12A 0.5325(2) 0.61914(11) 0.58304(15) 0.0184(6) 
C12B 0.6459(2) 0.60172(12) 0.6038(2) 0.0200(7) 
C13 0.7332(2) 0.63412(12) 0.6242(2) 0.0229(7) 
C14 0.8385(3) 0.61669(13) 0.6433(2) 0.0288(8) 
C15 0.8611(3) 0.56635(13) 0.6405(2) 0.0307(8) 
C15A 0.7771(3) 0.53143(13) 0.6223(2) 0.0285(8) 
C16 0.7984(3) 0.47870(14) 0.6189(2) 0.0369(9) 
C17 0.7175(3) 0.44464(13) 0.6051(2) 0.0331(8) 
C17A 0.6077(3) 0.46019(12) 0.5934(2) 0.0246(7) 
C18 0.5251(3) 0.42464(12) 0.5789(2) 0.0248(7) 
C19 0.4195(3) 0.44080(12) 0.5631(2) 0.0254(7) 
C20 0.3946(3) 0.49170(12) 0.5649(2) 0.0226(7) 
C20A 0.4739(2) 0.52891(11) 0.58372(15) 0.0192(7) 
C20B 0.4497(2) 0.58352(11) 0.58489(14) 0.0172(6) 
C20D 0.6687(2) 0.54868(12) 0.6073(2) 0.0210(7) 
C20C 0.5384(2) 0.51256(12) 0.59492(15) 0.0204(7) 
C21 0.3450(2) 0.60209(11) 0.58625(14) 0.0166(6) 
Table continued    
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Table 25 continued    
Atom x y Z Ueq 
C22 0.2097(2) 0.67413(11) 0.57638(15) 0.0176(6) 
C22A 0.1997(2) 0.73062(11) 0.56184(15) 0.0169(6) 
C23 0.1372(2) 0.76402(11) 0.58830(15) 0.0168(6) 
C23A 0.0928(2) 0.80754(11) 0.54793(15) 0.0171(6) 
C24 0.0491(2) 0.85137(11) 0.5721(2) 0.0188(6) 
C24A -0.0193(2) 0.88293(11) 0.5263(2) 0.0210(7) 
C24B -0.0509(3) 0.93435(12) 0.5429(2) 0.0252(7) 
C24C -0.1444(3) 0.95639(13) 0.5025(2) 0.0295(8) 
C24D -0.2040(3) 0.93065(12) 0.4443(2) 0.0263(7) 
C25 -0.0196(2) 0.81224(12) 0.3629(2) 0.0202(7) 
C26 -0.0424(2) 0.76153(12) 0.3486(2) 0.0253(7) 
C27 -0.0580(3) 0.74381(13) 0.2836(2) 0.0295(8) 
C28 -0.0502(3) 0.77671(14) 0.2321(2) 0.0324(8) 
C29 -0.0286(3) 0.82732(14) 0.2459(2) 0.0300(8) 
C30 -0.0133(2) 0.84514(13) 0.3107(2) 0.0256(7) 
C31 0.2110(2) 0.79875(12) 0.3995(2) 0.0236(7) 
C32 0.2059(3) 0.7714(2) 0.3410(2) 0.0340(9) 
C33 0.2392(3) 0.7939(2) 0.2882(2) 0.0506(12) 
C34 0.2784(3) 0.8429(2) 0.2934(2) 0.0605(15) 
C35 0.2839(3) 0.8696(2) 0.3508(2) 0.0488(11) 
C36 0.2499(3) 0.84778(14) 0.4036(2) 0.0326(8) 
C37 0.4159(2) 0.77850(12) 0.5110(2) 0.0236(7) 
C38 0.4712(3) 0.79672(14) 0.4645(2) 0.0329(8) 
C39 0.5206(3) 0.8439(2) 0.4731(2) 0.0470(11) 
C40 0.5152(3) 0.8733(2) 0.5277(3) 0.0539(13) 
C41 0.4602(3) 0.85575(14) 0.5739(2) 0.0438(10) 
C42 0.4114(3) 0.80885(12) 0.5659(2) 0.0296(8) 
C43 0.5863(2) 0.70419(12) 0.5438(2) 0.0214(7) 
C44 0.6265(2) 0.69626(12) 0.4870(2) 0.0258(7) 
C45 0.7068(3) 0.72779(14) 0.4732(2) 0.0324(8) 
C46 0.7455(3) 0.76739(14) 0.5149(2) 0.0385(10) 
C47 0.7060(3) 0.77592(13) 0.5716(2) 0.0331(9) 
C48 0.6273(2) 0.74414(12) 0.5858(2) 0.0251(7) 
C49 0.2699(2) 0.56799(11) 0.6132(2) 0.0201(7) 
C50 0.2993)3) 0.55424(12) 0.6805(2) 0.0248(7) 
C51 0.2349(3) 0.52197(13) 0.7080(2) 0.0325(8) 
Table continued    
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Table 25 continued    
Atom x y Z Ueq 
C52 0.1416(3) 0.50243(13) 0.6685(2) 0.0355(9) 
C53 0.1121(3) 0.51499(12) 0.6020(2) 0.0316(8) 
C54 0.1748(3) 0.54782(12) 0.5741(2) 0.0251(7) 
C55 0.1134(2) 0.65301(11) 0.5242(2) 0.0207(7) 
C56 0.0154(3) 0.64399(12) 0.5410(2) 0.0260(7) 
C57 -0.0729(3) 0.62755(13) 0.4924(2) 0.0331(8) 
C58 -0.0643(3) 0.62059(13) 0.4275(2) 0.0335(8) 
C59 0.0324(3) 0.63001(12) 0.4103(2) 0.0279(8) 
C60 0.1207(3) 0.64643(12) 0.4582(2) 0.0234(7) 
C61 0.0950(2) 0.75454(11) 0.64940(15) 0.0177(6) 
C62 0.1604(3) 0.75531(12) 0.7134(2) 0.0246(7) 
C63 0.1174(3) 0.74936(13) 0.7690(2) 0.0316(8) 
C64 0.0080(3) 0.74206(14) 0.7614(2) 0.0353(9) 
C65 -0.0580(3) 0.74097(13) 0.6984(2) 0.0308(8) 
C66 -0.0151(2) 0.74734(12) 0.6428(2) 0.0226(7) 
C67 0.0854(3) 0.86407(11) 0.6445(2) 0.0218(7) 
C68 0.1948(3) 0.87216(12) 0.6712(2) 0.0266(7) 
C69 0.2300(3) 0.88695(13) 0.7373(2) 0.0343(9) 
C70 0.1573(3) 0.89293(15) 0.7770(2) 0.0405(10) 
C71 0.0484(3) 0.88409(14) 0.7516(2) 0.0356(9) 
C72 0.0127(3) 0.86968(12) 0.6857(2) 0.0262(7) 
 
 
 
Extension of the acene skeleton was completed to produce pyrene hexacene diol 130 in an 
overall yield of 0.7%.  Aromatization of diol 130 should be accomplished through the use of 
SnCl2, THF, and HCl, but at this point has not been completed.   
Conclusion 
 We have utilized a synthetic pathway, which allows for the introduction of isopropyl 
substituents to the acene backbone.  This addition of a diastereotopic handle could be used in 
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the determination of the barrier to enantiomerization.  The reduction of acene quinones was 
achieved through in situ formation of an isopropylphenyl lithium adduct.  The addition of the 
isopropyl handle resulted in a 12º decrease in overall twist of the compound in comparison to 
the parent compound (138º to 126º).  The synthesis of the isopropyl containing crowded 
acenes using organolithium reagents opens the possibility of the addition of alternative 
substituents. 
Preliminary barrier to enantiomerization studies were attempted using Variable 
Temperature 
1
H NMR spectroscopy at temperatures up to 408 K.  However, even at 
maximum temperatures, coalescence of the isopropyl peaks was not observed, and a 
minimum peak separation of 1.6 and 6.0 Hz was obtained for compounds 113 and 115, 
respectively.  Future investigations utilizing more specialized NMR spectroscopic techniques 
(e.g., 2D NMR experiments) may allow for the determination of the barrier to 
enantiomerization, but the current data suggests the barriers for these systems are higher than 
24 kcal/mol. 
 Additional synthetic pathways were examined for the synthesis of additional endcaps 
(corannulene), central units (pyrene), and backbone extension (pyrene hexacene).  The 
corannulene capped acene and pyrene central unit targets were not successful at this time 
using currently known procedures.  While both targets remain of high interest, additional 
reaction conditions must be developed to pursue the targets.  Alternatively, pyrene hexacene 
diol 130 was synthesized in eight steps with a 0.7% overall yield.  Future attempts at 
aromatization may be possible using SnCl2.  Additionally, the development of the 
phenylisopropyl derivative should be accessible utilizing this synthesis.  
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Experimental Section 
General procedures.  Proton NMR spectra were recorded on a Varian AC MHz 
spectrometer operating at 400 MHz.  Carbon NMR spectra were recorded on a Varian AC 
400 spectrometer operating at 100 MHz.  Unless otherwise stated, all commercial chemicals 
and solvents were used as supplied.     
Dibenzo[ghi,mno]fluoranthene-1,2-dione (108).  Compound 108 was synthesized from a 
procedure adapted from Preda.
146
  An aliquot of 4M H2SO4 (11 mL) was added to a solution 
of corannulene (313 mg, 1.25 mmol) and acetonitrile (60 mL) in a 250-mL three-neck round 
bottom flask under argon.  Ammonium cerium sulfate (4.19 g, 6.62 mmol) was dissolved in 
4M H2SO4 (52 mL), and added to the corannulene solution, and heated to 70 ºC for 20 h.  
The orange solution was poured into water (300 mL), extracted using CH2Cl2 (2 x 250 mL), 
dried over Na2SO4, and concentrated to an orange solid that was collected via vacuum 
filtration.  The solid was subjected to column chromatography (silica gel; solvent:  hexanes, 
followed by 50% CH2Cl2‒hexanes, CH2Cl2), and an orange band was collected (Rf 0.37 TLC, 
silica gel; solvent: CH2Cl2).  The solvents were removed under reduced pressure to give 108 
as a yellow-orange solid (197 mg, 0.703 mmol, 35.0%): mp 316-320 ºC; 
1
H NMR (400 MHz, 
CDCl3) δ 7.71‒7.75 (t, J = 6.0 Hz, 3H), 7.78 (d, J = 2.8 Hz, 2H), 7.807.84 (t, J = 8.8 Hz, 
3H) ppm; 
13
C NMR (100 MHz, CDCl3) δ 124.5, 127.4, 128.1, 128.9, 130.1, 130.7, 134.5, 
134.8, 139.9, 142.1, 179.4 ppm. HRMS calcd for C20H8O2 280.05, found 280.0524. 
Pyrene-4,5-dione (107).  Compound 107 was synthesized from an adapted procedure by Hu 
et al.
141
  Pyrene (4.12 g, 20.4 mmol), CH2Cl2 (100 mL), and CH3CN (100 mL) were 
combined in a 500-mL screw-capped Erlenmeyer flask and stirred until pyrene was 
completely dissolved.  NaIO4 (20.2 g, 94.7 mmol), H2O (100 mL), and RuCl3·H2O (0.40 g, 
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1.95 mmol) were added sequentially to the pyrene solution and stirred at rt for 21 h.  Water 
(600 mL) was added, and the aqueous suspension was extracted using CH2Cl2 (4 x 200 mL).  
The organic phases were combined, washed with H2O (2 x 200 mL), dried over Na2SO4, and 
filtered.  The solvent was removed under reduced pressure.  The precipitate was collected via 
vacuum filtration and rinsed with methanol.  The orange solid was subjected to column 
chromatography (silica gel; solvent:  CH2Cl2), and an orange band was collected (Rf 0.40 
TLC, silica gel; solvent: CH2Cl2).  The solvent was removed under reduced pressure to give 
107 as an orange solid, which was used in the next step without any further purification (1.70 
g, 7.32 mmol, 36.0%).  An analytical sample was obtained by recrystallizing a small amount 
of 107 from CHCl3‒MeOH: mp 299‒302 ºC; 
1
H NMR (400 MHz, CDCl3) δ 7.74‒7.78 (d,  J 
= 8.0 Hz, 2H), 7.86 (s, 2H), 8.17‒8.20 (dd, J = 12.0, 8.0 Hz, 2H), 8.49‒8.51 (dd, J = 12.0, 8.0 
Hz, 2H) ppm; 
13
C NMR (100 MHz, CDCl3) δ 127.2, 128.0, 128.3, 130.0, 130.1, 131.9, 135.7, 
180.3 ppm. 
2,7-di-tert-butylpyrene (110).  Compound 110 was synthesized according to adapted 
procedures by Suzuki and Yamato.
151, 152
  AlCl3 (17.2 g, 129 mmol) was added to a solution 
of pyrene (16.3 g, 80.8 mmol) in t-butylchloride (400 mL) at 0 ºC.  The red solution was then 
allowed to warm to rt while stirring for 3 h.  Water (300 mL) was added, and the suspension 
was extracted using CH2Cl2 (2 x 250 mL).  The organic phases were combined, washed with 
H2O (2 x 150 mL), dried with Na2SO4, and filtered.  The solvent was removed under reduced 
pressure.  The precipitate was collected via vacuum filtration and rinsed with methanol to 
give 110 as a white solid (20.1 g, 63.9 mmol, 79.3%), which was used without any further 
purification. mp 208-210 ºC (lit
152
 209-211 ºC); 
1
H NMR (400 MHz, CDCl3) δ 1.58 (s, 18H), 
8.04 (s, 4H), 8.18 (s, 4H) ppm. 
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2,7-di-tert-butylpyrene-4,5,9,10-tetraone (111).  Compound 111 was synthesized from an 
adapted procedure by Hu et al.
141
  t-Butylpyrene (3.20 g, 10.2 mmol), CH2Cl2 (40 mL), and 
CH3CN (40 mL) were combined in a 500-mL screw-capped Erlenmeyer flask and stirred 
until the t-butylpyrene was completely dissolved.  NaIO4 (17.6 g, 82.3 mmol), H2O (50 mL), 
and RuCl3·H2O (0.25 g, 1.22 mmol) were added sequentially to the pyrene solution and 
stirred at 40 ºC for 21 h.  Water (200 mL) was added, and the aqueous suspension was 
extracted using CH2Cl2 (3 x 250 mL).  The organic phases were combined and washed with 
H2O (2 x 200 mL), dried over Na2SO4, and filtered.  The solvent was removed under reduced 
pressure.  The precipitate was collected via vacuum filtration and rinsed with methanol to 
give 111 as an orange-red solid which was used in the next step without any further 
purification (641 mg, 1.71 mmol, 16.8%). mp >400 ºC (lit
141
 >350 ºC);
1
H NMR (400 MHz, 
CDCl3) δ 1.56 (s, 18H), 8.48 (s, 4H) ppm. 
9,11-diphenyl-10H-cyclopenta[e]pyren-10-one (117).  Compound 117 was synthesized 
according to an adapted procedure by Pascal et al.
126
  Quinone 107 (3.85 g, 16.6 mmol), 1,3-
diphenylacetone (3.63 g, 17.3 mmol), and ethanol (400 mL) were combined in a 500-mL 
beaker and stirred.  NaOH (1.10 g, 27.5 mmol) was dissolved in H2O (5 mL), added 
dropwise to the suspension, and stirred at rt for 15 min.  The solution was then heated to a 
gentle reflux, at which point the beaker was immediately placed into an ice bath.  The 
precipitate was collected via vacuum filtration and rinsed with ethanol.  Recrystallization 
from CHCl3MeOH gave 117 as a brown solid, which was used in the next step without any 
further purification (3.96 g, 9.74 mmol, 58.8%). mp >400 ºC; 
1
H NMR (CDCl3, 400 MHz)   
7.23‒7.27 (t, J = 8.0 Hz, 2H), 7.39‒7.50 (m, 10 H), 7.66 (s, 2 H), 7.24‒7.75 (dd, J = 8.0, 1.2 
Hz, 2H), 7.86‒7.88 (dd, J = 7.6, 1.2 Hz, 2H) ppm; 13C NMR (CDCl3, 100.5 MHz)  123.6, 
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126.9, 127.0, 127.1, 127.3, 127.7, 128.1, 128.7, 130.0, 131.2, 132.3, 132.6, 147.9, 200.4 
ppm. 
9,14-Diphenyldibenzo[de,qr]tetracene-10,13-dione (118).  Pyrenecyclone 117 (280 mg, 
0.688 mmol), p-benzoquinone (612 mg, 5.66 mmol), and nitrobenzene (5 mL) were heated to 
reflux for 1 h in a screw-capped vial.  Methanol (40 mL) was added to the reaction contents 
and the precipitate was collected via vacuum filtration.  The red-orange solid was subjected 
to column chromatography (silica gel; solvent:  toluene, followed by 20% CH2Cl2–toluene).  
A red band was collected (Rf 0.50 TLC, silica gel; solvent:  10% ethyl acetatetoluene).  The 
solvent was removed under reduced pressure to give 118 as a red solid, which was used in 
the next step without any further purification (193 mg, 0.398 mmol, 58.0%).  An analytical 
sample was obtained by recrystallizing a small amount of 118 from CHCl3–MeOH: mp >400 
ºC; 
1
H NMR (400 MHz, CDCl3) δ 6.86 (s, 2H), 7.297.31 (m, 4H), 7.387.50 (m, 8H), 
7.747.76 (dd, J = 8.0, 0.8 Hz, 2H), 7.94 (s, 2H), 7.977.99 (dd, J = 7.6, 0.8 Hz, 2H) ppm; 
13
C NMR (100 MHz, CDCl3) δ 124.6, 126.0, 126.9, 127.0, 127.7, 128.6, 129.1, 130.5, 130.6, 
130.7, 137.0, 139.0, 140.6, 141.6, 187.1 ppm. 
9,11,20,22-tetraphenyltetrabenzo[c<sub>1</sub>d<sub>1</sub>,de,no,st]heptacene-
10,21-dione (114).  Quinone 118 (660 mg, 1.36 mmol), pyrenecyclone 117 (612 mg, 1.51 
mmol), and nitrobenzene (6 mL) were heated to reflux for 24 h in a screw-capped vial.  
Acetone (40 mL) was added to the reaction contents.  The precipitate was collected via 
vacuum filtration and rinsed with CH2Cl2 to give 114 as a greenish solid, which was used in 
the next step without any further purification (686 mg, 0.797 mmol, 58.5%):  mp >400 ºC.  
HRMS calcd for C66H36O2 860.27, found 860.2709. 
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10,21-bis(4-isopropylphenyl)-9,11,20,22-tetraphenyl-10,21-
dihydrotetrabenzo[c<sub>1</sub>d<sub>1</sub>,de,no,st]heptacene-10,21-diol (119). 
n-Butyllithium (2.5 M in hexanes, 0.5 mL, 1.3 mmol) was added to a solution of 1-bromo-4-
isopropylbenzene (0.2 mL, 0.8 mmol) and THF (5 mL) at -78 ºC, and the reaction was stirred 
for 40 min.  The isopropyl adduct was then added to a suspension of 114 (205 mg, 0.238 
mmol) in THF (5 mL) and stirred at rt for 24 h.  The reaction was quenched by the addition 
of water (10 mL), acidified with acetic acid (0.5 mL), poured into water (30 mL), and 
extracted with ethyl acetate (2 x 40 mL).  The organic phases combined and dried under 
Na2SO4.  The solvents were removed under reduced pressure.  The precipitate was collected 
via vacuum filtration and rinsed with methanol to give 119 as a yellow solid, which was used 
in the next step without any further purification (121 mg, 0.110 mmol, 46.2%). 
10,21-bis(4-isopropylphenyl)-9,11,20,22-tetraphenyltetrabenzo[c<sub>1</sub>d<sub> 
1</sub>,de,no,st]heptacene (113).  Diol 119 (77 mg, 0.070 mmol), SnCl2•2 H20 (1.34 g, 
5.94 mmol), HCl (0.5 mL), and THF (5 mL) were heated to 70 ºC for 1 h in a screw-capped 
vial.  Methanol (40 mL) was added, and the precipitate was collected via vacuum filtration.  
The red-orange solid was subjected to column chromatography (silica gel; solvent: hexanes; 
50% toluene‒hexanes).  A red band was collected Rf 0.50 TLC (silica gel; solvent: 10% ethyl 
acetatetoluene).  The solvent was removed under reduced pressure to give 113 as a red-
orange solid (29.4 mg, 0.028 mmol, 39.5%).  An analytical sample was obtained by 
recrystallizing a small amount of 113 from CHCl3–MeOH: mp >400 ºC; 
1
H NMR (400 MHz, 
CDCl3) δ 0.97‒1.00 (dd, J = 6.8, 3.2 Hz, 12H), 2.42‒2.29 (septet, J = 6.8 Hz, 2H), 6.196.21 
(d, J = 8.4 Hz, 4H), 6.50‒6.52 (d, J = 8.0 Hz, 4H), 6.54‒6.60 (m, 8H), 6.80‒6.84 (t, J = 6.8 
Hz, 8H), 6.86‒6.87 (d, J = 7.6 Hz, 4H), 6.95‒6.99 (t, J = 7.6 Hz, 4H), 7.06‒7.10 (t, J = 7.6 
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Hz, 4H), 7.69‒7.71 (d, J = 6.8 Hz, 4H), 7.79 (s, 4H) ppm; 13C NMR (100 MHz, CDCl3) δ 
23.6, 23.7, 33.8, 124.3, 124.6, 125.3, 126.0, 126.1, 126.6, 127.5, 127.8, 127.9, 128.3, 130.6, 
130.9, 132.8, 133.1, 133.3, 134.1, 135.0, 1356, 137.7, 141.6, 145.3 ppm.  HRMS calcd for 
C84H58 1066.4539, found 1066.4517.  Crystals suitable for X-ray analysis were obtained from 
CHCl3-MeOH. 
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Acenaphthene isopropyl anthracene (115).  n-Butyllithium (2.5 M in hexanes, 1.2 mL, 3.0 
mmol) was added to a solution of 1-bromo-4-isopropylbenzene (0.5 mL, 3.2 mmol) and THF 
(7 mL) at -78 ºC and stirred for 40 min.  The isopropyl adduct was then added to a refluxing 
solution of 116 (205 mg, 0.178 mmol) in benzene (15 mL) and reflux was continued for 1 h.  
The solution was then cooled to rt and stirred for 24 h.  The reaction was quenched by the 
addition of water (10 mL), acidified with acetic acid (0.5 mL), poured into water (30 mL), 
and extracted with ethyl acetate (2 x 40 mL).  The organic phases were combined and dried 
with Na2SO4.  The solvents were removed under reduced pressure.  The precipitate was 
collected via vacuum filtration and rinsed with methanol to give 121 as a brown-green solid, 
which was used in the next step without any further purification (88.6 mg, 0.063 mmol, 
35.7% crude yield).  Diol 121 (88.6 mg, 0.063 mmol), SnCl2•2 H20 (1.56 g, 6.91 mmol), HCl 
(0.5 mL), and THF (4 mL) were heated to 70 ºC for 1 h in a screw-capped vial.  Methanol 
(40 mL) was added, and the precipitate was collected via vacuum filtration.  The green solid 
was subjected to column chromatography (silica gel; solvent:  10% CH2Cl2‒hexanes).  The 
solvent was removed under reduced pressure to give 115 as a dark green solid (5.6 mg, 0.004 
mmol, 2.3%).  An analytical sample was obtained by recrystallizing a small amount of 115 
from CHCl3–MeOH: 
1
H NMR (400 MHz, CDCl3) δ 1.04 (s, 36H), 1.081.12 (dd, J = 7.2, 
8.4 Hz, 12H), 1.64 (s, 36H), 2.702.74 (p, J = 7.2 Hz, 2H), 6.75 (s, 4H), 7.047.06 (d, J = 
8.4 Hz, 4H), 7.53 (s, 4H), 7.78 (s, 4H), 8.018.03 (d, J = 8.4 Hz, 4H), 8.89 (s, 4H) ppm; 13C 
NMR (100 MHz, CDCl3) δ 22.5, 23.8, 31.8, 31.9, 33.0, 35.4, 35.7, 121.7, 122.1, 122.6, 
125.0, 127.6, 128.1, 128.8, 130.9, 133.6, 134.9, 136.7, 136.8, 138.0, 139.3, 148.1, 150.6, 
151.5 ppm.  
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5,8-dihydroxynaphthalene-1,4-dione (naphthazarin, 125).  Compound 125 was 
synthesized from an adapted procedure by Toribara et al.
149, 150
  Aluminum chloride (100 g) 
and NaCl (20 g) were heated to a melt on a hotplate at 190 ºC.  Maleic anhydride (10.2 g, 104 
mmol) and hydroquinone (11.3 g, 103 mmol) were added, and the solution was stirred at 240 
ºC for 1 h.  Water was carefully added (~350 mL), and the contents were heated to a boil 
until the mixture appeared homogenous.  Concentrated HCl (120 mL) was added, and the 
black solution stirred at rt overnight (16 h).  The precipitate was collected via vacuum 
filtration, dried, and boiled in toluene (200 mL) for 2 h.  The precipitate was removed via 
vacuum filtration, and the filtrate was concentrated under reduced pressure.  The resulting 
solid was stirred in hexanes (300 mL) for 1 h and collected via vacuum filtration to give 125 
as a metallic brown solid (3.35 g, 17.6 mmol, 17.2%), which was used without any further 
purification: mp 234-235 ºC; 
1
H NMR (400 MHz, CDCl3) δ 7.15 (s, 4 H), 12.42 (s, 2 H) 
ppm; 
13
C NMR (100 MHz, CDCl3) δ 111.8, 134.6, 172.8 ppm.  
5,8-dioxo-5,8-dihydronaphthalene-1,4-diyl diacetate (126).  Naphthazarin 125 (6.02 g, 
31.7 mmol), acetic anhydride (84 mL), and pyridine (0.5 mL) were heated to 90 ºC on a 
hotplate for 2 h and then stirred at rt for an additional 1 h.  Water (0.5 mL) was added, and 
the reaction mixture was allowed to stir overnight (14 h).  The precipitate was collected via 
vacuum filtration and washed with ethanol to give 126 as a yellow solid, which was used 
without any further purification (4.92 g, 17.9 mmol, 56.6%).  An analytical sample was 
obtained by recrystallizing a small amount of 126 from CHCl3MeOH:  mp 191-192 ºC; 
1
H 
NMR (400 MHz, CDCl3) δ 2.44 (s, 6 H), 6.80 (s, 2 H), 7.40 (s, 2 H) ppm; 
13
C NMR (100 
MHz, CDCl3) δ 21.0, 124.3, 131.0, 138.5, 147.5, 169.3, 183.1 ppm. 
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11,14-dihydroxy-9,16-diphenyldibenzo[de,uv]pentacene-10,15-dione (127).  
Pyrenecyclone 117 (1.03 g, 2.53 mmol), acetate 126 (687 mg, 2.51 mmol), and nitrobenzene 
(4 mL) were heated to 180 ºC for 24 h in a screw-capped vial.  The reaction contents were 
cooled to rt and CH2Cl2 (40 mL) was added, and the reaction was stirred for 21 h at rt.  The 
solvents were removed under reduced pressure, methanol (150 mL) was added, and the 
precipitate was collected via vacuum filtration to give 127 as a red solid, which was used in 
the next step without any further purification (561 mg, 0.990 mmol, 39.5%).  An analytical 
sample was obtained by recrystallizing a small amount of 127 from CHCl3MeOH:  mp 
>350 ˚C; 1H NMR (400 MHz, CDCl3) δ 7.34‒7.51 (m, 14H), 7.64‒7.66 (d, J = 8.4 Hz, 2H), 
7.96 (s, 2H), 7.99‒8.01 (d, J = 8 Hz, 2H), 12.26 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 
114.2, 124.7, 126.1, 127.1, 127.2, 127.9, 128.3, 128.4, 128.9, 129.2, 130.7, 130.8, 131.2, 
138.2, 141.2, 142.0, 156.3, 188.8 ppm; HRMS calcd for C40H22O4 566.1518, found 
566.1389.
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9,10,15,16-tetraphenyldibenzo[de,uv]pentacene-11,14-dione (128).  Phenyllithium (2M in 
dibutyl ether, 4 mL, 8 mmol) was added to a suspension of quinone 127 (394 mg, 0.695 
mmol) in dry THF (10 mL), and the contents were stirred for 24 h at rt under argon.  The 
reaction was quenched by the addition of water (10 mL), acidified with acetic acid (0.5 mL), 
poured into water (30 mL), and steam distilled to remove the organic solvents.  The 
precipitate was collected via vacuum filtration and washed with ethanol to give a light brown 
solid.  Recrystallization from CHCl3MeOH gave a brown solid, which was refluxed in 
nitrobenzene (1 mL) in a screw-capped vial for 1 h.  Methanol (15 mL) was added, the 
solution was allowed to sit for 16 h, and the precipitate was collected via vacuum filtration.  
The brown solid was subjected to column chromatography (silica gel; solvent: CH2Cl2).  The 
solvent was removed under reduced pressure to give 128 as a red solid, which was used in 
the next step without any further purification (146 mg, 0.213 mmol, 30.6%). mp > 350 ˚C; 1H 
NMR (400 MHz, CDCl3) δ 6.856.87 (d, J = 7.6 Hz, 2H), 6.997.02 (dt, J = 6.8, 2 Hz, 2H), 
7.16‒7.21 (m, 4H), 7.29‒7.33 (m, 2H), 7.417.47 (m, 4H), 7.587.68 (m, 6H), 7.74 (s, 2H), 
7.787.84 (m, 4H), 8.308.32 (m, 4H);  13C NMR (100 MHz, CDCl3) δ 124.5, 126.0, 126.2, 
126.5, 126.8, 127.1, 127.2, 127.3, 128.1, 128.2, 129.0, 129.2, 129.3, 130.6, 131.0, 131.9, 
132.4, 133.3, 137.2, 139.6, 139.7, 141.1, 142.9, 187.0 ppm.
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9,11,12,21,22,24-hexaphenyl-tetrabenzo[de,g<sub>1</sub>h<sub>1</sub>,pq,uv] 
octacene-10,23-dione (129).  Quinone 128 (1.03 g, 1.50 mmol), cyclone 117 (693 mg, 1.70 
mmol), and nitrobenzene (4 mL) were heated to 180 ºC in a screw-capped vial.  After 30 and 
60 min, additional cyclone 117 (372 mg and 101 mg, respectively) was added, and the 
solution heated for an additional 65 h.  Methanol (30 mL) was added, and the reaction 
contents were heated for 1 h.  Acetone (10 mL) was added, and the suspension was allowed 
to stand for 72 h.  The precipitate was collected via vacuum filtration, and the resulting red 
solid was subjected to column chromatography (silica gel; solvent: toluene).  A yellow band 
was collected (Rf 0.3 TLC, silica gel; solvent: toluene).  The solvent was removed under 
reduced pressure to give 129 as a red solid which was used in the next step without any 
further purification (574 mg, 0.540 mmol, 36.0%).  An analytical sample was obtained by 
recrystallizing a small amount of 129 from CHCl3‒MeOH: mp >350 ˚C; HRMS calcd for 
C82H46O2 1062.3498, found 1062.3467.  Crystals suitable for X-ray analysis were obtained 
from CHCl3-MeOH. 
9,10,11,12,21,22,23,24-octaphenyl-9a,10,23,23a-tetrahydrotetrabenzo[de,g<sub> 
1</sub>h<sub>1</sub>,pq,uv]octacene-10,23-diol (130).  Phenyllithium (2.0 M in 
diphenyl ether, 2 mL, 4 mmol) was added to a suspension of 129 (94.3 mg, 0.088 mmol) in 
THF (5 mL) and stirred at rt for 24 h.  The reaction was quenched by the addition of water 
(10 mL), acidified with acetic acid (0.5 mL), poured into water (30 mL), and extracted with 
ethyl acetate (2 x 40 mL).  The organic phases combined, dried under Na2SO4, and the 
solvents were removed under reduced pressure.  The precipitate was collected via vacuum 
filtration and rinsed with methanol to give 130 as a yellow solid (86.5 mg, 0.071 mmol, 
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74.4% crude); HRMS calcd for C94H58O2 1218.44, found 1218.4401.  Crystals suitable for X-
ray analysis were obtained from CHCl3-MeOH. 
Variable Temperature NMR Measurements on Compounds 113 and 115.  Compounds 
113 and 115 (~2 mg) were dissolved in 1,1,2,2-tetrachloroethane-d2 (1 mL), and 400 MHz 
1
H 
NMR spectra were recorded.  The sample was allowed to equilibrate at each of the chosen 
temperatures for 15 min prior to the collection of the spectrum.  Temperatures were 
measured by the use of a thermocouple inside the NMR spectrometer probe.  
X-ray Crystallography.  Samples of compounds 113, 129, and 130 were heated to a gentle 
reflux for less than a min in a loosely capped screw-capped vial.  The vial was then placed in 
the dark and allowed to sit for >1 week.  Crystals suitable for X-ray analysis formed upon the 
slow evaporation of solvent (CHCl3‒MeOH). 
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